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ABSTRACT 
Individuals on antipsychotic medications have been found to be 
disproportionately affected by overweight and obesity which increases their 
cardiometabolic risk.  Psychoeducation has been found to be an effective strategy for risk 
reduction of cardiometabolic risks. This intervention examined the effectiveness of a 
psychoeducational intervention in adults (aged 18 and above) with severe mental illness. 
The four session, 8 week intervention encouraged an increase in fruit and vegetable 
intake and engagement in physical activity. The conceptual frameworks included the 
Health Promotion Model and Chronic Care Model. Outcome measures included nutrition, 
physical activity and health promoting behaviors. Biological outcomes included weight, 
BMI, blood pressure, pulse, waist circumference, and waist-hip ratio. The Health-
Promoting Lifestyle Profile II (HPLP II) questionnaire was used to measure health 
promoting behaviors. The sample that completed the intervention consisted of 19 adults.   
Results of paired sample t-tests indicate that at the end of the intervention there 
were significant changes in the fruit intake, vegetable intake and time spent engaged in 
physical activity. Twelve of the 19 participants lost weight at the end of the intervention.  
However, there were no significant statistical changes in any biological variable.  Paired 
sample t-tests of the pre and post intervention 52 item HPLP II questionnaire indicated 
significant changes in the total 52 item scale, and physical activity and spiritual growth 
subscales. These findings suggest that an 8 week psychoeducational intervention can 
have an impact on the nutrition, physical activity and health promoting behaviors.  
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CHAPTER 1 
 INTRODUCTION 
For patients with schizophrenia, bipolar disorder, clinical depression, or other 
mental illnesses, the advent of psychotropic drugs improved the management of their 
symptoms and quality of life.  Antipsychotic drugs, now in a second generation form, are 
an example of drugs that have helped people live better lives.  Second generation 
antipsychotic medications (SGAs) also known as atypical antipsychotics have provided a 
clear benefit for many patients due to their reduced propensity to cause extrapyramidal 
effects often associated with older, conventional antipsychotics (Newcomer, 2004).  
However, adverse side effects have not evaded the use of antipsychotic drugs.  A major 
concern for the use of many antipsychotic medications is their significant association 
with weight gain, obesity, which in turn increases cardiovascular risk (Fleischhacker et 
al., 2008; Maayan & Correll, 2010). 
Weight Gain Associated with Antipsychotic Medications 
A disproportionate burden of weight gain has been noted in patients who are 
taking antipsychotic medications.  It has been indicated that none of the antipsychotic 
agents should be considered entirely body-weight-neutral, as the proportion of 
individuals who experience clinically significant weight gain (defined as ˃7% of 
pretreatment body weight) is greater with any antipsychotic agent than with placebo 
(Citrome, 2007).  All antipsychotic drugs have been found to cause notable weight gain 
in patients who are taking these agents for the first time (Tarricone, Ferrari, Serretti, & 
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Berardi, 2010).  The threat of weight gain has also been found to differ among different 
antipsychotic medications.  For example, multiple controlled studies have shown that all 
SGAs are associated with weight gain compared with placebo treatment, although some, 
such as olanzapine, clozapine, and quetiapine are more problematic than others such as 
ziprasidone and aripiprazole (Das, Mendez, Jagasia, & Labbate, 2012). 
Weight gain and obesity are increasingly becoming a growing public health 
concern facing Americans.  It has been estimated that more than one-third of adults in the 
United States are obese (CDC, 2012).  The escalation of various chronic medical 
conditions has also been attributed to obesity.  Obesity has been associated with increases 
in health complications such as cardiovascular diseases, hypertension, dyslipidemia, 
stroke, gallbladder disease, osteoarthritis, sleep apnea, respiratory problems, certain 
cancers and Type 2 diabetes.  Obesity has a great impact on health care spending.  In 
2008, obesity was associated with a total cost of $147 billion.  Medical costs for people 
who are obese were $1,429 higher than for those with normal weight (CDC, 2012). 
Up to 80% of individuals treated with antipsychotics have been found to suffer 
from medication-induced weight gain and 40% to 60% of persons with schizophrenia are 
obese as compared to 20% prevalence in the general United States adult population 
(Green, Patel, Goissman, Allison, & Blackburn, 2000).  Mental illness has been found to 
predispose individuals to becoming overweight or obese.  There is evidence that, 
compared with the general population, people with early-stage and/or without medication 
or with previously untreated schizophrenia and bipolar disorder are at increased risk of 
having increased body mass index (BMI) ≥ 25 kg/m2 corresponding to the medical 
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diagnosis of overweight, or BMI ≥30 kg/m2 corresponding to obesity and central obesity 
(De Hert et al., 2011; Maina, Salvi, Vitalucci, D'Ambrosio, & Bogetto, 2008).  Further 
evidence indicates that there is a 2.8 to 3.5 fold increase in the risk of obesity in patients 
with schizophrenia and 1.2 to 1.5 fold increase in patients with major depression or 
bipolar disorder.  Overall, weight gain is a well-established adverse effect of acute and 
maintenance antipsychotic treatment in patients with schizophrenia, and affects between 
15% and 72% of patients (De Hert et al., 2011; Maina et al., 2008).  Evidence further 
suggests that similar effects occur in patients with bipolar disorder on antipsychotic 
medications (De Hert, et al., 2011).  
According to Stahl (2008), some of the atypical antipsychotic agents are 
associated with significant cardiometabolic risks.  These risks include weight gain, 
obesity, dyslipidemia, diabetes, accelerated cardiovascular disease, and premature death.  
The “metabolic highway” (Stahl, 2008, p. 388 ) begins with increased appetite and 
weight gain which progresses to obesity, insulin resistance, and dyslipidemia with 
increase in fasting triglyceride level.  Ultimately, hyperinsulinemia advances to 
pancreatic beta cell failure, prediabetes and diabetes.  Once diabetes has been established, 
the risk for cardiovascular events and premature death is further increased. 
Many patients taking psychotropic medications gain enough weight to adversely 
affect their health.  Losing this weight, even after the psychotropic drug is discontinued, 
can be difficult (Sachs & Guille, 1999).  Obesity and medication related weight gain have 
also been observed to play a role in treatment outcomes by decreasing treatment 
adherence (Loh, Meyer, & Leckband, 2006; Weiden, Mackell, & McDonnell, 2004).  
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Patients may stop taking medication prematurely due to concern of weight gain.  In 
patients with  schizophrenia, data indicate that obese patients are 2.5 times more likely to 
miss taking their antipsychotic than those with BMI in the normal range  of less than 
25kg/m2 (Weiden et al., 2004).  Weight gain and obesity also have social consequences to 
the individuals who are affected.  It has been observed that excess weight and obesity 
leads to social withdrawal as a result of stigmatization and discrimination (Kurzthaler & 
Fleischhacker, 2001).  
There have been different theories regarding the mechanism underlying the 
association observed between antipsychotic medications and weight gain.  To date, 
mechanisms underlying antipsychotic cardiometabolic adverse effects are incompletely 
understood.   
Correll, Lencz and Malhotra (2011) discuss that  
recent clinical, molecular and genetic data suggest that: (a) antipsychotic-naive 
samples provide the greatest power for mechanistic study; (b) weight and 
metabolic effects can be discordant with overlapping and distinct mechanism; (c) 
antipsychotics affect satiety and energy homeostasis signaling; (d) the specific 
peptide mediating these effects is unknown but overlaps with those involved in 
idiopathic obesity; and (e) single nucleotide polymorphisms in genes encoding 
known neurotransmitter receptors and metabolic proteins are promising 
pharmacogenomic targets for countering adverse effects. (pp.97) 
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Weight Gain Independent of Antipsychotic Medications 
Other than antipsychotic medications, it has been observed that multiple factors 
contribute to the risk for obesity among patients with mental illness.  Behavioral and 
environmental risk factors contribute to overweight and obesity in patients with mental 
illness.  Lifestyle factors including poor dietary habits, lack of exercise or limited activity 
and inactivity due to negative symptoms have been hypothesized as contributors of 
weight gain in patients with schizophrenia (Basu et al., 2004).  Many patients with 
schizophrenia also live in group homes which may promote sedentary living and rarely 
provide diets to manage weight (Cjafetz, White, Collins-Bride, & Nickens, 2005).  
Physiological factors also play a role in weight gain.  
 Ryan and Thakore (2002) indicate that patients with schizophrenia have an 
increased propensity for storing excess fat as intraabdominal (visceral) adiposity.  Low 
baseline body mass index (BBMI) has also consistently been demonstrated to be a 
demographic risk factor with nearly every SGA (Gebhardt et al., 2009).  Low BBMI 
patients consistently gain weight at an increased rate compared with their heavier 
counterparts.  It has been suggested that low BBMI patients may have a higher resting 
metabolic rate and thus weight gain may be explained by a proportional decrease in 
metabolic rate in response to drug therapy.  However, low BBMI may be associated with 
the fact that many of these individuals have lost considerable weight due to their 
untreated illness.  Kurzthaler and Fleischhacker (2004) indicate that positive symptoms 
may lead to weight loss when patients stop eating to “cleanse” themselves or because of 
command hallucinations.  Weight increase in such patients may reflect symptom 
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reduction and improvement.  Additionally other significant predictors of risk of weight 
gain have been determined to be a younger age at treatment initiation, female sex, first 
exposure to antipsychotics, family history of high BMI, and non-smoking status 
(Gebhardt et al., 2009).  
Interventions Used for Weight Management 
  Modest weight loss has been associated with health benefits, including improved 
cardiovascular health among individuals who are overweight or obese (National Institutes 
of Health [NIH], 1998).  It has been recommended that weight prevention programs 
should be initiated when patients begin antipsychotic treatment in an effort to prevent or 
decrease weight gain (Littrell, Hilligoss, Kirshner, Petty, & Johnson, 2003).  Dixon et al. 
(2009) also recommend that individuals with schizophrenia who are overweight 
(BMI=25.0 -29.9) or obese (BMI ≳30.0) should be offered a psychosocial weight loss 
intervention to promote weight loss.  The key elements of psychosocial interventions 
proposed for weight loss include psychoeducation focused on nutritional counseling, 
caloric expenditure, and portion control; behavioral self-management including 
motivational enhancement, goal setting, regular weigh-ins, self-monitoring of daily food 
and activity levels; and dietary and physical activity modification.  
 Clinical guidelines also recommend that adults should avoid sedentary lifestyles 
by being active (U.S. Department of Health and Human Services [USDHHS], 2008).  
Additionally, it is indicated that some physical activity is better than none and adults who 
participate in any amount of physical activity gain some health benefits. Regular activity 
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has also been recommended for adults with chronic conditions due to the resulting health 
benefits.  
There is an increasing interest to develop treatment alternatives to control weight 
gain in patients on antipsychotic medications.  Maayan and Correll (2010) suggest three 
strategies that can be utilized to manage antipsychotic induced weight gain that include 
switching to a less metabolically adverse antipsychotic, adjunctive behavioral treatments, 
and adjunctive pharmacological treatments.  However each of these strategies has been 
found to be only modestly effective. Furthermore weight was not decreased to 
pretreatment level particularly in antipsychotic-naive patients even when interventions 
were co-initiated with antipsychotics. Among different behavioral interventions, group 
and individual treatment, dietary counseling and cognitive-behavioral therapy seem to be 
similarly effective. Among 15 different pharmacological strategies the most evidence 
available was for metformin; however there was lack of availability of head-to-head trials 
comparing individual pharmacologic interventions. Another study by Faulkner, Cohn, 
and Remington (2007) reviewed interventions to reduce weight gain in schizophrenia and 
concluded that there was insufficient evidence to support the general use of adjunctive 
pharmacological interventions to reduce weight gain in schizophrenia.  
Literature has indicated lack of support for the use of pharmacological 
interventions. Psychoeducational interventions are important for the target patient 
population, and may decrease cardiometabolic risk factors. More importantly the 
psychoeducational intervention may impart knowledge and skills that may promote 
healthy lifestyles in the target population. 
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Significance of the Project 
There is a growing practice problem facing clinicians on how to prevent weight 
gain in patients on antipsychotic medication.  One recommended approach to treating 
antipsychotic-induced-weight gain is switching the antipsychotic (Das, Mendez, Jagasia, 
& Labbate, 2012). Das et al. found that there are a few studies evaluating if the switch 
works, and there is almost no evidence about the long-term weight loss benefits of 
switching. 
The psychopharmacology of weight loss with drugs that have been studied to 
promote weight loss in patients on antipsychotic medications is poorly understood (Das et 
al., 2012).  Additionally, there is little evidence that pharmacologic treatment is superior 
to behavioral treatment. Despite the lack of research on combining behavioral and 
pharmacologic treatment, Das et al. doubt the effectiveness of pharmacological 
treatments without behavior change.   
 This project is significant as it is clear that interventions targeting behavioral 
modification are the cornerstone of weight loss treatment in clients on antipsychotic 
medications (Das et al., 2012).  Weight gain has an appalling impact on those who 
experience it and on the society at large.  Implementation of interventions that focus on 
prevention of weight gain or obesity is crucial.  It has been reported that patients with 
severe mental illness have limited access to general somatic health care and receive less 
somatic health care than patients without mental illness (Fleischhaker et al ., 2008).  
Furthermore even when somatic health care is provided it has been reported to be of a 
lower quality than that for patients without serious mental disorders.  The disparities in 
 
 
 
20 
 
health service delivery and treatment provision can therefore hamper the recognition of 
overweight and obesity in patients with mental illness.   
Many clinicians will be interested in whether non-pharmacological interventions 
like the implementation of a psychoeducation intervention for patients on antipsychotic 
medication will prevent weight gain or lead to weight loss.  This project intervention 
which focuses on a non-pharmacological psychoeducation intervention for patients on 
antipsychotic medications with the aim of preventing weight gain or obesity is an 
important step. The implementation is also an attempt to develop a best practice approach 
that can improve patient outcomes in an already vulnerable population.  Advanced 
Practice Nurses (APNs) have a key role to play in improving outcomes for vulnerable 
populations.  The overall implication for APNs is therefore to implement interventions 
that will target weight gain and obesity in patients managed by antipsychotic 
medications.  Given the significant threat of antipsychotic medication related weight gain 
to the course of mental illness, quality of life, health complications, health outcomes and 
healthcare spending, it is imperative to examine whether a nurse practitioner-led non-
pharmacological intervention will facilitate prevention of weight gain. 
Target Population 
The proposed project was conducted at a Community Mental Health Clinic in a 
mid-western city in the United States. The target population included patients taking at 
least one antipsychotic medication.  The populations served at the project site are 
community case management clients who have serious mental illness or co-occurring 
disorder (mental health, medical health, or substance use).   
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Purpose of the Project 
The prevalence of overweight and obesity in the mental health population is 
concerning. Overweight and obesity is the precursor of increased cardiometabolic risks. 
Unhealthy lifestyle and environmental factors further escalate the problem.  It is therefore 
important to investigate whether the implementation of a psychoeducation intervention 
will be beneficial to an already vulnerable population.  
The purpose of the project was therefore to (a) study the effect of  an 
individualized psychoeducation intervention on  nutrition, physical activity, weight, BMI, 
blood pressure, waist circumference, waist/hip ratio in adult patients (aged 18  and above) 
with severe mental illness who are on antipsychotic medications; and (b) evaluate the 
effect of an individualized psychoeducation intervention on health promoting lifestyles of 
adult patients (aged 18 and above) with severe mental illness who are on antipsychotic 
medications. 
Translational Project Question 
The guiding questions in the  project were  (a) What effect does an individualized 
psychoeducational intervention have on  nutrition,  physical activity, weight, BMI, blood 
pressure,  waist circumference, waist/hip ratio in adult patients (aged 18 and above) with 
severe mental illness who are on antipsychotic medications ? (b)  What effect does an 
individualized pychoeducational intervention have on health promoting lifestyles of adult 
patients (aged 18 and above) with severe mental illness who are on antipsychotic 
medications? 
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CHAPTER 2 
 REVIEW OF LITERATURE 
The purpose of this project was to implement a psychoeducational intervention 
that would increase awareness of nutrition and physical activity for adults (aged 18 and 
above) with severe mental illness who are taking antipsychotic medications.  The second 
purpose of the intervention was to determine if the intervention had any effect on weight, 
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting 
lifestyles among this group of adults.   
  The purpose of this chapter is to review literature relative to non-
pharmacological interventions that are used to prevent weight gain in patients on 
antipsychotic medications.  Modes of delivery of education in patients with mental illness 
are also discussed.  To explore current literature focusing on interventions for prevention 
of weight gain in patients on antipsychotic medications, the following databases were 
reviewed: CINAHL; Cochrane Review; PubMed; Proquest: and PsycINFO.  Keywords or 
phrases for this review included weight gain; weight loss; weight prevention; 
psychoeducation; antipsychotics; second generation antipsychotics; atypical 
antipsychotics; non-pharmacologic; behavioral therapies; schizophrenia; and metabolic 
syndrome.  Keywords used to review modes of education delivery were education; 
mental health; antipsychotics; and systematic review.  Additionally, the reference lists of 
all retrieved literature were reviewed for potential inclusion.  
The risk of metabolic syndrome associated with various atypical antipsychotic 
medications has been described across numerous studies with higher effects seen for 
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certain antipsychotic medications on weight gain, waist circumference, fasting 
triglyceride level, and glucose levels (Riordan, Antonini, & Murphy, 2011).  Studies have 
shown that the prevalence of metabolic syndrome and cardiometabolic risk factors, such 
as overweight, hypertension, dyslipidemia and glucose abnormalities are substantial in 
patients with mental illness in the United States.  The Clinical Antipsychotic Trial of 
Intervention Effectiveness (CATIE) clinical trials, which included 1361 patients 
receiving antipsychotic treatment, documented a 35.8 % prevalence of metabolic 
syndrome (McEvoy et al., 2005).    
Another study by Correll et al. (2010) involved a one-day national 
cardiometabolic screening program for patients in a variety of public mental health 
facilities, group practices, and community behavioral health clinics.  The study was 
carried out between 2005 and 2008 and included a total of 10,084 patients at 219 sites.  
The study found that for the overall sample, the mean waist circumference was 41.1 
inches for men and 40.4 inches for women; 27% were overweight (body mass index 
[BMI] 25.0-29.9 kg/m2), 52% were obese (BMI ≥ 30.0kg/m2), 51% had elevated total 
cholesterol ( ≥ 200mg/dl), 59% had a low level of high-density lipoprotein cholesterol (< 
40mg/dl for men or < 50mg/dl for women), 45% had elevated triglycerides ( ≥ 150 
mg/dl), and 33% had elevated fasting glucose ( ≥ 100mg/dl).  
To clinicians, an increasingly difficult practice problem is how to prevent weight 
gain in patients on antipsychotic medications in order to improve patient outcomes.  
Riordan et al. (2011) recommend that programs aimed at improving clinical measures 
associated with metabolic syndrome may decrease important risk factors, improve 
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patients’ quality of life and significantly reduce healthcare costs.  One suggested 
approach to treating antipsychotic-induced weight gain is switching the antipsychotic 
(Das et al., 2012).  According to Das et al., additional long-term studies are required to 
influence the clinical practice since the psychopharmacology of weight loss with some of 
these medications is poorly understood.  Furthermore, Das et al. found little evidence that 
pharmacologic treatment is superior to behavioral treatment. Of medications studied, only 
sibutramine and topiramate showed appreciable modest weight loss of approximately 2 to 
3 kg in short-term studies compared to placebo.    Despite the lack of research combining 
behavioral and pharmacologic treatment, Das et al. doubt the effectiveness of 
pharmacologic treatments without behavior change.  It is therefore likely that 
interventions targeting behavioral modification are the cornerstone of weight loss 
treatment in clients on antipsychotic medications (Das et al., 2012).  According to Das et 
al., behavioral treatments have been found to lead to modest weight loss, compared to 
controls, ranging from 0.5 kg to 4.0 kg.  
Many clinicians will be interested in whether non-pharmacological interventions 
like the implementation of a psychoeducation intervention for patients on antipsychotic 
medication will prevent weight gain or lead to weight loss.  According to  Dixon et al. 
(2009) in the Schizophrenia Patient Outcomes Research Team (PORT),  psychosocial 
treatment recommendations and summary statements recommend that individuals with 
schizophrenia who are overweight (BMI=25.0-29.9) or obese (BMI≥30.0) should be 
offered a psychosocial weight loss intervention that is at least three months in duration to 
promote weight loss.  The key elements of psychosocial interventions for weight loss 
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include psychoeducation focused on nutritional counseling, caloric expenditure, and 
portion control; behavioral self-management including motivational enhancement; goal 
setting; regular weigh-ins, self-monitoring of daily food and activity levels; and dietary 
and physical activity modification.  
Dixon et al. (2009) mention that while the evidence for intervention for weight 
loss is strong enough to warrant a recommendation, the current state of the literature 
exploring psychosocial interventions for the prevention of weight gain among individuals 
with schizophrenia is not substantial enough to warrant a formal recommendation by the 
PORT.  The absence of randomized controlled studies has been a key setback in 
developing evidence-based interventions that can manage weight loss among this 
population.  To date only a few randomized control trials (RCTs) targeting the prevention 
of weight gain among individuals with schizophrenia who had recently begun taking 
antipsychotic medications have been published.   
Due to the lack of consensus on management of antipsychotic medication induced 
weight gain, an attempt has been made to review all relevant literature pertaining to 
current strategies.  To adequately develop a comprehensive weight prevention 
intervention for clients on antipsychotic medications, investigating existing programs and 
reviewing elements that contributed to their success is necessary.  The goal of the review 
is for the literature to guide and support the design of the intervention that will contribute 
to the greatest outcome.   
Two approaches to non-pharmacological management of weight management 
have been identified in the literature including psychoeducation and cognitive behavioral 
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interventions.  The existing literature reviewed will be compared by study design, 
methods, theoretical framework, study setting, participants, inclusion and exclusion 
criteria, variables, scales and statistical tests, findings, limitations of the study, and 
implications for clinical practice. 
Meta-Analyses 
Five key meta-analyses concerned with weight management in patients on 
antipsychotic medications have been reviewed.  Das, Mendez, Jagasia, and Labbate 
(2012) performed a comprehensive literature review of all controlled clinical trials for 
pharmacological and/or behavioral management of SGA-induced weight gain in 
schizophrenia patients by searching PubMed and Google Scholar.  They used 
combinations of search terms schizophrenia, weight gain, weight loss, antipsychotics, 
behavioral therapies, non-pharmacologic, second-generation antipsychotic, and switching 
with limits of clinical trials.  A total of 63 studies were reviewed and analyzed. The 
studies were combined using meta-analytic techniques to assess the impact on weight 
change of various pharmacologic and behavioral treatments.  Studies were classified in 
the same group if they addressed a similar question (i.e., weight loss caused by a specific 
pharmacologic intervention).  The analysis showed that sample sizes were generally 
small.  Clinical trials were six weeks to one year, and weight loss was modest with any 
treatment.  Several adjunctive pharmacologic treatments showed no weight loss; 
sibutramine, metformin, and topiramate showed some benefit.  Amantadine and orlistat 
were somewhat less effective and had lower rates of tolerability.  The analysis also found 
that among behavioral therapies, nutritional counseling combined with exercise showed 
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the most benefit.  Behavioral therapies showed modest but most consistent benefits 
compared with controls.  The authors concluded that scheduled pharmacologic treatment 
to prevent weight gain or promote weight loss in schizophrenia patients on SGA therapy 
was limited based on the review.  They also concluded that switching antipsychotic 
agents has not been established as a long-term solution and additional long-term studies 
were required to influence clinical practice.  This study suggests that non-pharmacologic 
interventions may be beneficial to clients on antipsychotic medications.  
Alvarez-Jimenez, Hetrick, Gonzalez-Blanch, Gleeson, and McGorry (2008) 
carried out a systematic review and meta-analysis of RCTs.  The inclusion criteria were 
RCTs of a specific non-pharmacological adjunctive intervention aimed at prevention or 
controlling antipsychotic-induced weight gain, with at least 75% of participants who had 
been diagnosed with schizophrenia-spectrum disorders using either the Diagnostic and 
Statistical Manual (DSM) or International Code of Diagnosis (ICD).  A total of ten trials 
with interventions lasting between eight weeks and six months were included in the meta-
analysis.  The participants were either young adults with recent-onset psychosis or adults 
with chronic schizophrenia, hospitalized or out-patients, and receiving treatment with 
first- or second-generation antipsychotic drugs.  The primary outcome was considered to 
be mean change in body weight and BMI by the end of the intervention, while the 
secondary outcome measure included mean change in both body weight and BMI by 
follow-up.  Additional secondary outcome measures comprised mean change of ratings of 
quality of life, medication adherence and relapse rates.  A total of 482 patients were 
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included in the RCTs that compared non-pharmacological interventions with treatment as 
usual.  
Alvarez-Jimenez et al. (2008)  found that there was a statistically significant 
reduction in mean body weight for participants in the non-pharmacological intervention 
groups compared with those on treatment as usual (weight mean difference, WMD=-2.56 
kg, 95% CI -3.20 to -1.92kg, p< 0.0001) .  The pooling treatment effects of mean BMI 
change across all interventions yielded similar significant results in favor of the non-
pharmacological interventions (WMD=-0.91kg/m2, 95% CI -1.13 to -0.68kg/m2, 
p<0.0001).  The study also observed that pooling treatment effects change in body weight 
and in BMI demonstrated statistically significant advantages of non-pharmacological 
interventions at follow-up.  The study concluded that adjunctive non-pharmacological 
interventions, whether individual or group interventions, or cognitive behavioral therapy 
with nutritional counseling, were effective in reducing or attenuating antipsychotic-
induced weight gain compared with treatment as usual.  Additionally treatment effects of 
non-pharmacological interventions were maintained to follow-up.  Similarly this meta-
analytic review consistently found that non-pharmacological interventions led to 
significant weight loss in patients on antipsychotic medications.  These findings are 
notable and support the potential of a non-pharmacological psychoeducation intervention 
to facilitate weight loss in participants aged 18 years and older who are on antipsychotic 
medications.  
Faulkner, Cohn, and Remington (2007) reviewed studies with the objective of 
determining the effects of both pharmacological (excluding medication switching) and 
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non-pharmacological strategies for reducing or preventing weight gain in individuals with 
schizophrenia.  Key databases and the Cochrane Schizophrenia Group’s trials register and 
reference sections within relevant articles were searched.  The authors also hand searched 
key journals and contacted first authors of each relevant study and other experts to collect 
further information.  The selection criteria included RCTs that compared any 
pharmacological or non-pharmacological intervention for weight gain (e.g., diet and 
exercise counseling including those with elements of cognitive and /or behavioral 
modification) with standard care or other treatments for individuals with schizophrenia or 
schizophrenia-like illnesses.  Weighted mean differences of the change in weight from 
baseline were calculated.  Where heterogeneity existed (determined by a chi-square test), 
a random-effects model was used.  The primary outcome measure was weight loss.   
Twenty-three RCTs met the inclusion criteria for the review (Faulkner et al., 
2007).  Five trials assessed a cognitive/behavioral intervention while eighteen trials used 
a pharmacological adjunct.  Two cognitive/behavioral interventions showed significant 
mean weight change at the end of the treatment (2 RCTs, n=104, WMD=-3.38kg, CI -
4.81 to -1.96).  Three cognitive/behavioral trials showed significant treatment effect at 
end of treatment (3 RCTs, n=129, WMD=-1.69 kg, CI -2.77 to -0.61).  Pharmacological 
adjunct showed an overall treatment effect (9 RCTs, n=273, WMD=-2.97 KG, CI -4.48 
to -1.46).  The study concluded that modest short-term weight loss can be achieved with 
selective pharmacological and non-pharmacological interventions.  According to the 
authors, interpretation of the study was limited by the small number of studies, small 
sample sizes, short study durations, variability of the interventions themselves, and 
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intensity and duration of study.  The sample sizes in most studies ranged between 14 and 
171.  The duration of the trials ranged between six weeks and twenty-four weeks.  The 
average duration was found to be approximately twelve weeks.  All the five 
cognitive/behavioral studies were not double-blind due to the inherent difficulty involved 
in disguising psychosocial interventions.  Out of the eighteen pharmacological 
interventions, sixteen were double blind and two were open.  
A systematic review was conducted on the effectiveness of interventions designed 
to control weight gain in schizophrenia (Faulkner, Soundy, & Lloyd, 2003).  A total of 16 
studies met the inclusion criteria.  Eight studies which included behavioral (including diet 
and /or exercise) interventions reported consistent small reductions in or maintenance of 
weight.  The authors concluded that incorporating multiple components of diet, exercise 
and/or behavioral counseling were all successful in limiting weight gain.  Additionally 
they concluded that both dietary and exercise counseling set within a behavioral 
modification program is necessary for sustained weight control.  The authors mention 
that weak study designs and small sample sizes observed in many studies were a 
limitation.  
Faulkner and Cohn (2006) undertook a selective review of interventions for 
weight gain and metabolic disturbance in the general population and in individuals 
treated with antipsychotic medications focusing on RCTs in schizophrenia.  The review 
analyzed both pharmacological and non-pharmacological interventions.  Four RCTs of 
non-pharmacological interventions were identified.  They had a total of 208 participants 
(98 men and 110 women) with an average age of 36.14 years and an average weight of 
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87.99 kg at the start of the study (as well as average BMI of 29.09 kg/m2, reported in 
three of the studies).  The participants were primarily outpatients taking olanzapine in 
three studies.  The length of the interventions ranged from 14 weeks to three months.  
Three studies involved cognitive-behavioral group interventions incorporating education 
and discussion regarding diet and physical activity, and one study used one-on-one 
dietary counseling.  Faulkner and Cohn mention that the intervention sessions included 
individual and group work, written exercises, tests, and discussions to develop and 
rehearse self-monitoring skills (for example, modifying urges to overeat and changing 
snacking habits) and set regularly reviewed healthy-eating lifestyle goals.  Three studies 
involving cognitive-behavioral interventions confirmed that modest weight-gain 
prevention or weight loss is possible in the short term, although there were no statistically 
significant findings in two studies.  The authors mention that the limitation of the review 
was the small number of rigorous RCTs of short-term duration and the small sample 
sizes. 
Literature Review on Psychoeducation Interventions 
The aim of psychoeducation (or patient education/teaching) in patients with 
mental illness is to increase knowledge and understanding of their illness and treatment 
(Xia, Merinder, & Belgamwar, 2011).  Psychoeducational interventions involve the 
interaction between the information provider and mentally ill person.  Psychoeducation 
interventions are brief and inexpensive making them attractive to managers and policy 
makers.  
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A study was carried out over a six month period with an aim of assessing the 
effect of an education intervention on antipsychotic-induced weight gain among patients 
with schizophrenia who were being treated with olanzapine (Littrell, Hilligoss, Kirshner, 
Petty, & Johnson, 2003).  The study was a quasi-experimental design with 70 patients 
with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder.  Patients were 
randomly assigned to an intervention group or a standard care group.  For over four 
months, the intervention group participated in weekly psychoeducation classes that 
focused on nutrition, exercise, and living a healthy lifestyle.  The participants were 
followed for an additional two months to assess weight change.  
The study found a statistically significant difference in weight change between the 
two groups at post-treatment and at endpoint (Littrell et al., 2003).  At the endpoint of the 
study, the mean weight change of the intervention group was -0.06 pounds, while the 
mean weight change in the standard care group was an additional 9.57 pounds.  The study 
concluded that a structured educational intervention might have a positive effect on 
antipsychotic-induced weight gain among patients with schizophrenia.  Study limitations 
included unclear effects of dosing of olanzapine since it was prescribed in a flexible-dose 
manner and concomitant medication use in some patients.  The relatively short study 
duration and lack of measuring subjects’ extraneous variables such as medication history 
and familial trends for subjects in the two groups was also recognized as a limitation.  It 
is encouraging that their study showed that a simple group psychoeducation intervention 
attained a clinically meaningful outcome for participants.  
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Wu et al. (2008) carried out a 12 week study to compare the effectiveness of 
several interventions in reducing the weight gain associated with the use of antipsychotic 
agents in patients with schizophrenia.  The study included patients who were 18-45 years 
of age.  Patients were randomized to receive metformin alone (750 mg per day), placebo 
alone, lifestyle intervention plus metformin, or lifestyle intervention and placebo.  
Lifestyle interventions consisted of a psychoeducation approach with an emphasis on the 
role of eating and exercise on weight management, including a dietary intervention 
recommended by the American Heart Association, and exercise programs initiated at the 
study site and continued at home.  Out of the 128 eligible patients, 118 completed the 
study: 30 patients in the lifestyle intervention plus metformin group, 30 patients in the 
metformin alone group, 29 patients in the lifestyle intervention plus placebo group, and 
29 patients in the placebo alone group. 
Wu et al. (2008) found that lifestyle-plus metformin group had a mean decrease in 
BMI of 1.8 (95% CI, 1.3-2.3).  The metformin-alone group had a mean decrease of 1.2 
(95% CI, 0.9 to -1.5) in BMI.  Lifestyle group had a mean decrease of 0.5(95%CI, -0.3 to 
-0.8).  The placebo group had a mean increase in weight gain of 1.2 (95% CI, 0.9 -1.5).  
Analysis of variance (ANOVA) was used to compare all continuous variables.  Statistical 
comparisons among the interventions showed the metformin plus lifestyle group had 
results that were statistically significant compared to all other interventions.  In addition, 
all interventions were superior to placebo.  The study concluded that all interventions 
were better than placebo alone for producing weight loss in patients with schizophrenia 
who had gained weight from atypical antipsychotic medications.  The limitation when 
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interpreting this study is that some interventions were multicomponent making it difficult 
to define which strategies worked best.  
Vreeland, Minsky, Gara, and Toto (2010) carried out a study to examine the 
effectiveness of a manualized, psychoeducational wellness toolkit called the Solutions for 
Wellness (SFW).  The aim of the study was to examine whether mental health consumers 
who volunteered to participate in an intensive group intervention with the SFW program 
increased knowledge about wellness and changed their attitude/intentions to pursue 
healthier lifestyle choices.  The primary outcome measure was change in knowledge and 
attitudes/intentions.  Secondary outcomes were change in BMI, weight, systolic and 
diastolic blood pressure, pulse, waist circumference, hope and clinician rating of clinical 
status.  Thirty-four participants with mental illness participated in an intensive 10-week 
manualized group wellness program while the control group contained 31 participants 
who did not receive the treatment. 
Vreeland et al. (2010) found statistically significant pre-post improvement in 
knowledge (p= 0.001), attitudes (p= 0.007), BMI (p= 0.0066), weight (p= 0.0079) and 
systolic blood pressure (p= 0.0007).  The study also found that the intervention group 
evidenced statistically significant improvements in knowledge about and 
attitudes/intentions toward making healthier lifestyle choices, weight, and BMI in 
comparison to the group that did not receive any intervention.  The study concluded that 
an educational intervention may increase mental health consumers’ knowledge about 
wellness and bring about changes in attitudes/intentions to pursue healthier lifestyle 
choices.  The relatively short study duration and lack of randomization of participants 
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were recognized as limitations of this study.  What is encouraging is that even a 10 week 
psychoeducation intervention attained a clinically significant outcome for participants.  
Menza et al. (2004) carried out a prospective study with the purpose of testing the 
feasibility and efficacy of a multimodal weight control program for overweight and obese 
mentally ill adults who had gained weight while taking atypical antipsychotic 
medications.  The participants were 31 subjects with schizophrenia or schizoaffective 
disorder (DSM-IV), taking an atypical antipsychotic, who participated in a 52-week 
Healthy Living program.  The program incorporated nutrition counseling, exercise, and a 
behavioral intervention designed to help adults with schizophrenia implement healthy 
lifestyle changes.  Strategies used in the program included behavioral strategies, 
brainstorming, positive feedback and special teaching approaches.  A group receiving 
usual care contained 20 subjects.  The primary outcomes which were measured in the 
intervention group included BMI and weight while secondary outcomes included 
hemoglobin A1c level, systolic and diastolic blood pressure, and cholesterol level 
compared from baseline to endpoint (Menza et al., 2004).  Twenty of the 31 subjects 
completed the program.  The study found statistically significant pre-post improvements 
in weight (p<0.02), BMI (p< 0.02), hemoglobin A1c (p< 0.01), diastolic (p< 0.001) and 
systolic (p< 0.05) blood pressure, exercise level (p< 0.003), nutrition knowledge (p< 
0.0001), stage of change (exercise p< 0.0001), and weight (p< 0.008) in the intervention 
group.  Weight and BMI decreased significantly (p= 0.01) in the intervention group 
compared with the “usual care” group, who gained weight.  
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The study concluded that individuals with schizophrenia and schizoaffective 
disorders benefited from a weight control program that focused on nutrition, exercise, and 
motivation.  Additionally the program resulted in clinically significant reductions in 
weight, BMI, and other risk factors for long-term poor health, including hemoglobin A1c.  
Lack of random assignment and a small sample size were identified as study limitations.  
A key inference from this study is that a non-pharmacological intervention can lead to 
weight loss and also improve other risk factors for poor health compared to no 
intervention in clients with mental illness.  
Brown and Chan (2006) carried out a randomized controlled trial using the Lilly 
“Meaningful Day” manual which delivers health promotion interventions and focuses on 
weight reduction.  The Meaningful Day manual uses techniques such as motivational 
interviewing, health education, and food and activity diaries among the interventions.  It 
also facilitates access to local community facilities.  A total of 28 patients were 
randomized to treatment (n= 15) or control (n= 13) group.  Only 7 (47%) subjects and 10 
(77%) controls completed the study.  The mean change in weight between the subjects (- 
0.40 kg weight loss) and controls (+ 1.11kg weight gain) was statistically significant, p= 
0.01.  The mean change in BMI between the subject (- 0.02 kg/m2) and the controls (+ 
0.41 kg /m2) was also statistically significant, p= 0.02.  The study concluded that the 
intervention produced significant health gains to participants.  However the findings of 
this study should be treated with caution due to the high attrition rate.  
Another study carried out an electronic search of published articles pertaining to 
the use of behavioral interventions in individuals with schizophrenia using PsyINFO and 
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Medline (Loh, Meyer, & Leckband, 2006).  A total of 23 studies with a total sample of 
701 participants was identified.  The types of behavioral interventions consisted of 
behavioral modification techniques, caloric restriction, and psychoeducation.  Weight 
loss was reported in 19 studies, while the remaining studies showed either maintenance of 
baseline weight or minimum weight gain.  The authors concluded that much of the 
literature was methodologically unsound and only applicable to inpatient settings.  
Furthermore high drop-out rates and the absence of extended post-treatment follow-up 
still limit the conclusions regarding general efficacy of behavioral treatment of obesity in 
patients with schizophrenia. 
Literature Review on Cognitive Behavioral Interventions 
Three articles involving the use of cognitive behavioral interventions were 
identified.  Zhang et al. (2012) carried out a study to compare the effectiveness of a 
cognitive-behavioral weight loss intervention in obese subjects with psychiatric disorders 
and those without.  This study was a 12 month naturalistic study of weekly group or 
individual cognitive-behavioral management in 222 obese patients with psychotic 
spectrum disorders (n=47), other psychiatric disorders (n= 49), and no psychiatric 
disorders (n=126).  Participants were either self-referred or referred by other health care 
professionals.  The mean age of the participants was 49.2 ± 14.1 years old and the mean 
BMI was 43.7± 9.6.  The treatment consisted of cognitive behavior therapy from 
Northwestern University Medical School’s People at Risk Weight Control Program.  
Weekly treatment was delivered by a team consisting of psychotherapist, a nutritionist, 
and an exercise physiologist in individual sessions lasting 45 to 50 minutes or group 
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sessions lasting 60 to 75 minutes.  The assignment of group or individual treatment was 
based on clinical judgment or patient’s preference.  The treatment provided enhanced 
self-monitoring of food intake and exercise habits, behavioral contracting, cognitive 
restructuring, and stimulus control.   
The primary outcome measure in the study by Zhang et al. (2012) was the 
absolute and relative change in weight and BMI.  Secondary outcomes included 
percentage of patient with 5% or more weight loss at the end of treatment.  The study 
found that at the 12 month follow up, 62 patients (27.9%) remained in treatment.  The 
entire sample lost 3.54 ± 9.02 pounds from baseline (i.e. 1.34%± 3.39% loss ) of baseline 
weight at the 3month follow up, 6.27 ± 14.62 pounds (2.33% ± 5.22%) at 6 months, 7.98 
± 17.21 pounds (2.96% ± 6.23%) at 9 months , and 8.47 ± 18.75 pounds ( 3.15% ± 
6.70%) pounds at 12 months (p< 0.001).  Patients with a psychotic spectrum disorder had 
greater percent baseline weight loss at 12 months (5.1% ± 9.3%) than patients with other 
psychiatric disorders and with no psychiatric disorder (2.7% ± 5.5% and 2.4 ±6.3%).  
Patients with psychotic spectrum disorder also had a greater percent BMI loss at 9 
months (2.1 ± 3.5 kg/m2) and 12 months (2.3 ± 4.1 kg/m2) than those with no psychiatric 
disorder (1.1 ± 2.3 and 1.2 ± 2.4 kg/m2) respectively.  Weight loss of 5% or more 
occurred in 42.6% of patients with psychotic spectrum disorders versus 18.4% and 23.0%  
for those with other psychiatric disorders or with no psychiatric disorder (p< 0.001) 
respectively.  The study found that attrition was higher for those with no psychiatric 
disorder (p = 0.001) or with other psychiatric disorders (p=0.036), for those who 
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participated in a lower proportion of group sessions (p=0.002), for those with more 
depression (p=0.028), and those with lower baseline BMI (p=0.030).   
Zhang et al. (2012) concluded that patients with psychotic spectrum disorders had 
greater weight loss than other obese patients.  They also concluded that nonadherence and 
depression should be targeted to enhance weight loss success.  This study is significant as 
it is the first study to compare weight loss outcomes of a non-pharmacological treatment 
programs between patients with psychotic disorders and individuals with nonpsychotic 
psychiatric conditions or no psychiatric illness.  The authors identified study limitations 
as lack of randomization, the lack of blinding, and the possibility that patients with 
psychotic spectrum disorders received more clinical attention that resulted in them 
staying in the program longer and in turn playing a role in their greater weight loss.   
Weber and Wyne (2006) conducted a 16-week pilot study using a randomized-
control group design to examine the effectiveness of a cognitive behavioral group 
intervention based on the Diabetes Prevention Project (DPP) lifestyle intervention for 
individuals who were taking atypical antipsychotics.  The study included people with 
schizophrenia or schizoaffective disorder who were being treated in a large urban public 
mental health clinic system.  The content of the program was based on cognitive 
behavioral strategies to promote risk reduction that were demonstrated to be successful in 
the DPP.  A total of 17 participants were randomized to either the 16 week cognitive 
behavioral group intervention (n= 8) or treatment as usual group (n =9).  The cognitive 
behavioral group participants lost an average of 5.4 lb or 2.9% of body weight, and those 
in the control group lost 1.3 lb or 0.6% body weight (Weber & Wyne, 2006).  The range 
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of weight loss for the treatment group was from 1 to 20 lbs.  The researchers concluded 
that the pilot study demonstrated that weight loss is possible with cognitive behavioral 
interventions in a population with psychotic disorders.  The major limitation of the pilot 
study was the small sample size that made it impossible to show significance. 
Kwon et al. (2006) carried out a study with the objective of assessing the efficacy 
of a weight management program designed for outpatients taking olanzapine for 
schizophrenia or schizoaffective disorder.  The main components of the study were diet 
and exercise management, which were based on cognitive and behavioral therapy.  A 
total of 48 patients were enrolled in a 12-week, randomized, multicenter weight 
management study.  A total of 33 patients were randomly assigned to the intervention 
group which received olanzapine within a weight management program.  Fifteen patients 
were allocated to a control group in which they were given olanzapine treatment as usual.  
Weight, body mass index (BMI), and measurements of safety and quality of life were 
evaluated.  A total of 36 patients (75%) in the intervention and the control group 
completed the study.  The study found a significant difference in weight (-3.94 ± 3.63 vs. 
-1.48 ± 1.88 kg, p= 0.006) and BMI (-1.50 ± 1.34 vs. -0.59 ± 0.73, p= 0.007) change 
from baseline to endpoint between the intervention and control groups respectively.  The 
study concluded that a cognitive behavioral weight management program was effective in 
terms of weight reduction in patients with schizophrenia or schizoaffective disorder 
taking olanzapine.  The authors mention that the limitation of the study included a small 
sample size and short study duration.  Additionally, disproportionate dropout rate is a 
limitation in the study; of the 36 patients who completed the study, 22 were in the 
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intervention group, while 14 were in the control group.  The strength of this study 
includes the use of a comparison group and randomization of the participants.  
Modes of Delivery of Educational Interventions 
It is imperative that the design and content of educational program take into 
account the strengths and limitations of the learners.  Patients with mental illness may 
have deficits in attention, memory, motor skills and social functioning.  It is more 
challenging to educate recipients of mental healthcare due to the cognitive impairments 
associated with some psychiatric disorders, and due to the growing need for providing 
greater information about the potential risks of some mental health treatments (Jeste, 
Dunn, Folsom, & Zisook, 2008).  Psychoeducational approaches have been developed to 
increase patients’ knowledge of, and insight into, their illness and its treatment (Xia, 
Merinder, & Belgamwar, 2011).  It is expected that this increased knowledge and insight 
will enable clients to cope in a more effective way with their illness, thereby improving 
their prognosis.   
 Xia et al. (2011) searched the Cochrane Schizophrenia Group Trials Register. 
Their objective was to assess the effects of psychoeducational interventions compared 
with standard methods of knowledge provision.  The selection criteria included all 
relevant RCTs focusing on psychoeducation and /or related serious mental illness 
involving individuals or groups.  Quasi-randomized trials were excluded.  A total of 
5,142 participants from 44 trials conducted between 1988 and 2009 were included.  The 
median study duration was 12 weeks.  The studies found that incidences of non-
compliance were lower in the psychoeducation groups in the short term (n=1400, RR 
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0.52 CI 0.40 to 0.67, NNT 11 CI 9 to 16).  This finding held for the medium and long 
term as well.  Relapse appeared to be lower in psychoeducation groups (n =1214, RR 
0.70 CI 0.61 to 0.81, NNT 9 CI 7 to 14).  Furthermore data suggested that 
psychoeducation promotes better social and global functioning.  Further evidence 
suggested that participants receiving psychoeducation were more likely to be satisfied 
with mental health services (n=236, RR 0.24 CI 0.12 to 0.50, NNT 5 CI 5 to 8) and have 
improved quality of life.  
Various patient education interventions have been developed and can be used for 
individuals with mental disorders.  Fernandez, Evans, Griffiths, and Mostacchi (2006) 
carried out a systematic review with an aim of investigating the efficacy of educational 
interventions in relation to psychotropic medications for consumers with mental health 
disorders.  The review included RCTs that compared the effects of various educational 
interventions on knowledge retention, compliance to medication and treatment, incidence 
of relapse and insight into illness. Subjects were aged 18 years and over with mental 
disorders.  Structured information was defined as receiving information in a planned 
manner (e.g., videotape, role-play, discussion) and the unstructured information consisted 
of information that was delivered in an inconsistent manner (e.g., incidental teaching).  
The study found that patients who were provided with education of either type 
demonstrated a significant increase in the level of knowledge and compliance compared 
with those who were not.  A structured patient education using both written and verbal 
methods followed by discussion of the contents proved effective in this patient 
population. Further evidence also suggested that consumers who were provided with 
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multiple education session had greater knowledge gains in the short term (up to 1 month); 
however the effectiveness of multiple sessions in the long term (2 years) is inconclusive 
in this patient group.  The authors therefore concluded that the review provides evidence 
that multiple education sessions are better than a single education session in improving 
knowledge in relation to medications and insight into illness.  Evidence from the trials 
also demonstrated that structured educational interventions delivered at frequent intervals 
are useful as part of the treatment programs for people with mental illness.  
Pitkänen et al. (2012) carried out a study with the aim of estimating the 
effectiveness of patient education methods on quality of life and functional impairment of 
patients with schizophrenia.  A total of 311 patients were randomly assigned to computer-
based (information technology [IT]) patient education group (n=100), conventional 
education with standard leaflets and discussions (n =106), and standard treatment 
(n=105).  In the IT education group, a patient participated in a systematic computer-based 
education program (Mieli.Net) together with a nurse.  The content covered information 
on illness, treatment, well-being, support and patients’ right.  In the conventional 
education group patients received information in written leaflets.  At the beginning of 
each session the patients received an information leaflet on the topic and discussion 
focused on that information.  The average length of the patient education sessions was 30 
minutes.  In the standard treatment group patients received patient education according to 
usual ward procedures.  In Finland patient education varies between hospital and units, 
there are no standardized and uniform guidelines.  Depending on individual nurses’ own 
motivation and inclination, patients may receive individual oral information on their 
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illness and its treatment in care meetings.  The patient in the standard treatment may have 
also received written material.  Nevertheless, educational activities were less systematic 
and varied between study wards and shifts in the standard treatment group.   
Participants in the study were followed up 12 months later.  The primary outcome 
was quality of life while secondary outcome was functional disability.  The study found 
that patients’ global quality of life improved and functional disability decreased 
significantly in all education groups.  Therefore there were no significant differences 
between groups in these outcomes.  The study concluded that there is no evidence to 
support a particular education method as the best way to improve patient’s quality of life 
or improve functional ability.  The study also concluded that computer-based patient 
education remains a suitable alternative for some patients.  Study limitation includes a 
high dropout rate of 27.7%.  Strength of the study includes randomization of participants 
to different education groups. 
Jeste, Dunn, Folsom, and Zisook (2008) reviewed studies that compared the 
effects of multimedia (video-or computer based) educational aids with those of routine 
procedures to inform healthcare consumers about medical evaluations or management.  
Most of the investigations were conducted for non-psychiatric patients.  They found that 
there are still very few studies concerning patient education programs that have been 
developed and tested in clinical settings among patients with mental illness.  A total of 37 
RCTs trials were identified.  Nearly two-thirds of the studies  (n=23) reported that 
multimedia educational aids produced better understanding of information compared to 
routine methods which include pamphlets or leaflets.  The authors concluded that 
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multimedia educational aids hold promise for improving the provision of complex 
medical information to patients and caregivers.  
Recently Välimäki, Hatönen, Lahti, Kuosmanen, and Adams (2012) evaluated the 
effects of psychoeducational interventions using information and communication 
technology (ICT) as a means of educating and supporting people with schizophrenia or 
related psychosis.  They searched the Cochrane Schizophrenia Group Trials Register 
(2008, 2009, and September 2010).  They inspected references of identified studies for 
further trials and contacted these authors for additional information.  The selection 
criteria were all RCTs comparing ICT as a psychoeducational and supportive tool with 
any other type of psychoeducation and supportive intervention or standard care.  They 
included six trials with a total of 1063 participants.  They found no significant differences 
in the primary outcomes (patient compliance and global state) between 
psychoeducational interventions using ICT and standard care.  
Summary and Conclusion 
The discussed literature review supports the use of a variety of interventions 
rather than no intervention in management of weight in patients on antipsychotic 
medications.  What is encouraging is that even studies with small sample sizes attained a 
meaningful outcome for participants that could improve their health outcomes.  The 
intervention that was implemented in the current project attempted to make a similar 
effort by evaluating the effectiveness of an eight week psychoeducation intervention on 
weight, BMI and other risks factors that predispose clients on antipsychotic medications 
to prediabetes and diabetes.  The intervention exposed the participants to an 
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individualized multimedia psychoeducation with the emphasis on the role of eating and 
exercises on weight management. The intervention also involved the use of structured 
patient education using both written and verbal methods followed by discussion during 
multiple education sessions as supported by the literature.  
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CHAPTER 3 
CONCEPTUAL FRAMEWORK 
The purpose of this project was to implement a psychoeducational intervention 
that would increase awareness of nutrition and physical activity for adults (aged 18 and 
above) with severe mental illness who are taking antipsychotic medications.  The second 
purpose of the intervention was to determine if the intervention had any effect on weight, 
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting 
lifestyles among this group of adults.  This chapter describes the Health Promotion Model 
(HPM) that was used as a conceptualizing framework to direct the psychoeducation 
intervention.  The Chronic Care Model (CCM) was utilized to understand the 
complexities of implementing the proposed project in a Community Mental Health Clinic 
is also discussed.  
Health Promotion Model 
The HPM first appeared in nursing literature in 1982 and was revised in 1996 
based on changing theoretical perspectives and empirical findings (Pender, Murdaugh, & 
Parsons, 2006).  The HPM model is shown in Figure 1.  The HPM has its philosophical 
roots in Reciprocal Interaction World View in which humans are viewed holistically, but 
parts can be studied in the context of the whole.  Human beings therefore interact with 
their environment and shape it to meet their needs and goals.  While implementing the 
psychoeducational intervention, the facilitator understood that participants can be 
successfully engaged in actions to achieve goals that are perceived as possible and that 
can result in valued outcomes.  Additionally the facilitator understood that to change 
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behavior, the participants had to change how they think.  The main goal of the 
psychoeducation intervention was therefore to influence participants to engage in health 
promoting behaviors.  The central focus of the model is on eight beliefs that can be 
assessed and lead to the implementation of appropriate interventions. 
 
 Figure 1:  Health Promotion Model. Adapted from The Health Promotion Model, Figure 
2-4, p.50, Pender, Nola J.; Murdaugh, Carolyn L.; Parsons, Mary Ann. Health Promotion 
in Nursing Practice, 5th edition, © (2006). Reprinted by permission of Pearson Education, 
Inc, Upper Saddle River NJ.  (See Appendix A) 
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In total there are five key concepts in nursing defined as a basis for the HPM 
(Pender et al., 2006).  They include the person, environment, nursing, health and illness. 
The person is considered to be a biopsychosocial organism that is partially shaped by the 
environment but also seeks to create an environment in which natural and acquired 
human potentials can be fully expressed (Pender et al., 2006).  On the other hand the 
environment is the social, cultural and physical context in which the life course unfolds.  
The person does not live in isolation but interacts with the environment.  Persons on 
antipsychotic medications are predisposed to overweight and obesity as a result of 
medication effects and individual characteristics.  It has also been found that social and 
cultural factors further influences their risk to weight gain.  While using HPM during the 
intervention, the facilitator viewed the participants holistically with the belief that they 
have the ability to transform their environment by using strategies that were acquired 
from the pyschoeducational sessions.  The goal was to assist the participants to acquire 
targeted health behaviors that would lead to an overall improvement of their physical 
health.  
 Nursing is defined as collaboration with individuals, families, and communities 
to create the most favorable conditions for the expression of optimal health and high-
level well-being (Pender et al., 2006).  During the intervention the facilitator collaborated 
with the participants and a community in a mid-western city in the United States with the 
goal of improving the health outcomes of clients on antipsychotic medications.   
Health in reference to the individual is the actualization of inherent and acquired 
human potential through goal-oriented behavior, competent self-care, and satisfying 
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relationships with others (Pender et al, 2006).  The facilitator understood that the 
psychoeducational intervention was aimed at influencing health promoting behaviors in 
participants with the goal of improving participants’ physical health outcomes.  
Pender et al. (2006) identify illnesses as discrete events throughout the life span.  
Illness can be either of short (acute) or long (chronic) duration that can hinder or facilitate 
one’s continuing quest for health.  Overweight and obesity are a chronic conditions that 
has been determined to be a threat to the well-being of persons on antipsychotic 
medications.  While using the HPM as a guiding framework for the intervention, the goal 
of the facilitator was to prevent weight gain, a major threat that faces clients on 
antipsychotic medications.  The key to improving high rates of overweight and obesity of 
this population is targeting lifestyle factors.  Furthermore engaging in health promotion 
initiatives was a key role of the facilitator.   
Components of Health Promotion Model 
Individual Characteristics and Experiences 
Individual characteristics and experiences include prior related behavior and 
personal factors (Pender et al., 2006).  The facilitator acknowledged that these two factors 
might influence individual’s health-promoting choices.  The facilitator used a holistic 
approach while assisting participants to formulate a plan of action.  During the 
intervention the facilitator obtained an initial assessment of reported daily intake of cups 
of fruits and vegetables and reported weekly participation in physical activity. Other 
characteristics of the participants that influenced health behavior that were obtained 
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during the intervention included gender, ethnicity, age, weight, height, blood pressure, 
pulse, waist and hip measurements and calculated BMI and waist/hip ratio.   
Behavior-Specific Cognition and Affect 
Behavior-specific cognition and affect that were targeted during the intervention 
included (a) perceived benefits of action; (b) perceived barriers to action; (c) 
interpersonal influences; (d) situational influences; and (e) commitment to a plan of 
action.  The facilitator understood that assisting participants to identify behavior-specific 
cognitions and affect would facilitate self-efficacy in participants and enhance the ability 
to perform the required action.  
Perceived benefits of action are perceptions of the positive or reinforcing 
consequences of undertaking a health behavior (Pender et al., 2006).  During the 
intervention, each participant was asked to identify at least three benefits of eating fruits 
and vegetables daily.  Additionally, participants also identified at least three benefits of 
participating in at least 30 minutes of moderate-physical activity on most days of the 
week.   
Perceived barriers to action are the perceptions of the constraints and personal 
costs of undertaking a health behavior (Pender et al., 2006).  During the intervention 
participants identified barriers that prevented them from eating more fruits, vegetables 
and engaging in physical activity.   
Interpersonal influences include family, peer and providers (Pender et al., 2006).  
Interpersonal influences  have been cited to provide norms, social support, role model 
perceptions concerning the behaviors, beliefs, or attitudes of relevant others in regard to 
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engaging in a specific health behavior.  The role of the facilitator during the intervention 
was to provide education and support to participants with the aim of influencing 
participants to eat more fruits, vegetables and engage in physical activity.  The facilitator 
also provided positive social support with the aim of influencing health promoting 
behavior change.  
Situational influences include options, demand characteristics and aesthetics 
(Pender et al., 2006).  The situational influence serves to support the perceptions of the 
compatibility of life context or the environment with engaging in a specific health 
behavior. Situational factors that affected the participants’ ability to attain predetermined 
goals included access to fruits and vegetables. Situational influences also affected the 
ability of the participants to meet their physical activity goals.  During the intervention 
the facilitator utilized multiple supported follow-up to reinforce positive behavior and 
attainment of goals. Participants were also assisted in revising their goals when needed.  
Commitment to a plan of action is the intention to carry out a particular health 
behavior including the identification of specific strategies to do so successfully (Pender et 
al., 2006).  The identification of perceived benefits and barriers by participants enabled 
them to set goals related to their fruit and vegetable intake and engage in physical 
activity.  While participating in the intervention each participant set a personal goal that 
would assist them towards eating more fruits and vegetables.  Participants also set a 
second goal that assisted them towards participating in 30 minutes of moderate physical 
activity on most days of the week.  The supported follow-up and multiple sessions 
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offered by the facilitator were intended to reinforce positive behavior and promote 
adherence to goals.  
Behavior Outcome-Health Promoting Behavior 
According to Pender et al. (2006) the health promoting behavior is the desired 
behavioral end point or outcome of health decision making and preparation to action.  
The psychoeducation intervention emphasized that participants work towards eating 
recommended amount of cups of fruits and vegetables per day and participate in at least 
30 minutes of physical activity most days of the week by setting individual goals.  It was 
believed that when participants defined their goals, it assisted them to identify a plan that 
could lead them to change their behavior.  Additionally, health-promoting lifestyle 
activities beyond dietary intake were assessed as an outcome.  
Summary  
The HPM was selected as the conceptual framework for the psychoeducation 
intervention as it identifies contextual factors that influence health behavior.  Further, the 
model facilitated identification of components of the intervention.   
The Chronic Care Model 
The CCM was utilized to institute change during the implementation of the 
proposed project (Wagner, 1998).  The CCM is an evidence-based initiative developed 
with the aim of reducing the gap between scientific advances regarding the prevention, 
diagnosis, monitoring and treatment of chronic diseases and subsequent health outcomes 
for patients.  The CCM was developed for use in primary care, but it has been applied to 
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a variety of healthcare settings and targeted populations.  The CCM model is shown in 
Appendix B.  
The CCM was used to assess the project site prior to the implementation of the 
proposed intervention.  The CCM focuses on interventions on six main components of 
care that include community resources and policies, healthcare organizations, self-
management support, delivery system design, decision support, and clinical information 
systems.  These elements are designed to work together to strengthen the provider-patient 
relationship and improve health outcomes.  The aim of the CCM is to transform the daily 
care for patients with chronic illnesses from acute and reactive to proactive, planned, and 
population-based.  At the core of this model are improved functional and clinical 
outcomes for patients’ disease management resulting from productive interactions 
between informed, activated patients and prepared, proactive teams of healthcare 
professionals.  
Components of Chronic Care Model 
Community Resources and Policy 
The role of the community is to mobilize resources to meet needs of patients by 
encouraging patients to participate in effective community programs (Wagner, 1998).  
One way to achieve this goal is by forming partnerships with community organizations to 
support and develop interventions that fill gaps in needed services.  Additionally the 
community should also advocate for policies to improve patient care.  It was also 
important for the facilitator to assist participants in identifying resources in their 
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communities that would enable them to increase fruit and vegetable intake and participate 
in physical activity.  
Health Care Systems 
The health care system is the organization desiring to implement the CCM 
(Wagner, 1998).  The goal of CCM is to create a culture for organizations to promote 
safe, high quality care.  A system seeking to improve chronic illness must be motivated 
and prepared for change throughout the organization.  It was therefore necessary to assess 
the organization’s perception of the proposed intervention and determine if the 
organization was motivated to change.  It was also imperative to assess if the 
organization had the staff to sustain the intervention post its completion.   
During the implementation of the project support from senior leadership was 
necessary.  The facilitator of the project collaborated with the team leader for the Case 
Managers and the Case Managers in order to have the necessary support to implement the 
intervention.  During the intervention at the Community Mental Health Clinic in a mid-
western city in the United States, the facilitator utilized the case managers as a resource 
to encourage clients to participate in this psychoeducational intervention that might 
improve their health outcomes.  The facilitator also shared the findings of the project with 
the leadership team of the Community Case Management after the completion of the 
project.  
Self-Management Support 
This is a key component of the CCM designed to empower and prepare patients to 
manage their health and health care (Wagner, 1998).  To accomplish this goal during the 
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intervention strategies that were utilized by the facilitator included (a) assessment, (b) 
goal-setting, (c) action planning, (d) problem solving, (d) utilization of a placemat as a 
cue to remind participants to engage in health promoting behaviors, and (e) support and 
follow-up.  Through these strategies, the facilitator formed a partnership with the 
participants that enhanced a collaborative approach.   
Delivery Systems Design and Decision Supports 
The role of the delivery system design is to assure the delivery of effective, 
efficient clinical care and self-management support (Wagner, 1998).  Defining roles of 
team members ensures the provision of evidenced-based care.  Complex patients may 
need more intensive management (care or case management) to optimize clinical care and 
self-management.  The role of case managers was to identify participants that would 
benefit from the proposed pyschoeducational intervention.  During the intervention, 
participants received reminder phone calls from the facilitator and the case managers to 
remind them of appointments.  At the study site, clients are usually assisted with bus 
tokens if they are in need of transportation.  Case Managers assisted the participants with 
bus tokens if needed.  The team leader for the Case Managers provided logistic supports.  
A good example was the assignment of a research room where the intervention was 
implemented. Additionally, an agency laptop was provided to the facilitator to use for 
data collection and storage during the intervention. 
Clinical Information Systems 
The role of clinical information systems is to organize patient and population data 
to facilitate improvement of patient care (Wagner, 1998).  Ortiz (2006) indicates that 
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registries can be established without the availability of an electronic health record (EHR) 
with the use of common software tools such as Excel.  The facilitator utilized an Excel 
spreadsheet for data collection.  The project site uses CareLogic as the EHR.  CareLogic 
is a comprehensive flexible clinical, administrative and financial management system 
designed specifically for behavioral health professionals for meaningful use. During the 
intervention, secondary data that were abstracted from the site’s EHR included 
participants’ diagnoses and medications. During the project, the intervention and the 
outcomes were not documented in the agency’s EHR. 
Summary  
The CCM was selected as it provided a conceptual framework to explore the 
complexities of implementing a psychoeducational intervention project in a Community 
Mental Health Clinic.  The CCM assisted the facilitator of the intervention to engage the 
organization’s leadership and staff members to support the success of the 
implementation. The CCM also enabled the identification and utilization of agency’s 
resources to enhance the implementation. More importantly, the CCM assisted the 
facilitator to understand how to engage individuals to make informed choices that could 
lead to improved health outcomes.  
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CHAPTER 4 
METHODS 
The purpose of this project was to implement a psychoeducational intervention 
that would increase awareness of nutrition and physical activity for adults (aged 18 and 
above) with severe mental illness who are taking antipsychotic medications.  The second 
purpose of the intervention was to determine if the intervention had any effect on weight, 
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting 
lifestyles among this group of adults.     
This chapter describes the methods and strategies that were utilized to develop 
and implement a psychoeducational intervention in adults on antipsychotic medications at 
a Community Mental Health Clinic in a mid-western city in the United States.  The 
project was conceptualized in four phases (a) development of the intervention; (b) 
assessment of the project implementation site; (c) implementation of the psychoeducation 
interventions; and (d) analysis of outcomes of the intervention.  After receiving approval 
from Human Research Review Committee, Grand Valley State University (Appendix C) 
and from the Mental Health agency (Appendix D), participants were recruited by method 
of referrals from case managers. The participants in the project were English speaking 
and were referred by the case managers from the Case Management case load. Another 
inclusion criterion was a participant must be taking at least one antipsychotic medication. 
An exclusion criterion was any patient determined to be acutely mentally ill.  This is 
because psychoeducation is not considered an appropriate intervention in the acute phase 
of illness.   
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Study Site 
The intervention was carried out at a Community Mental Health Clinic in a mid-
western city in the United States in the Spring of 2014.  Many of the clients served by 
this clinic are poor, homeless, or uninsured.  The mental illnesses range from 
schizophrenia and bipolar disorder to anxiety disorder. These clients generally have 
difficulty accessing health care.  Issues like alcohol abuse and drug use are also prevalent 
among this population. Financial difficulties were a potential barrier for participants to 
meet project goals. The challenges included lack of transportation and access to fruits and 
vegetables.  
Site Population 
The number of mental health clients in Spring 2014 served under the Case 
Management caseload consisted of 266 clients.  Of the 266 clients, 135 clients (50.8%) 
are male, 126 clients (47.4%) female, and 5 clients (1.9%) have unknown gender.  The 
ethnicity represented include 2 clients (0.8%)  Native American, 57 clients (21.4%)  
Black, 20 clients (7.5%)  Hispanic, 160 clients (60.2%)  White, 3 clients (1.1%)  
Korean/Asian, 7 clients (2.6%) two or more races and 17 clients (6.4%) have their 
ethnicity unreported.  The age representation included 60 clients (22.6%) age range 18-
29, 205 clients (77.1%) age range 30-64, and 1 client (0.4%) over age 64.  
Project Sample 
A total of 23 participants were recruited for this project (Table 1). The sample had 
more males than females. Over half of the participants were White in ethnicity.  The 
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minimum age was 25 and the maximum age was 55. The mean age for the participants 
was 44.96.  All the 23 participants completed session 1.   
Table 1 
Demographic Characteristics of Participants 
________________________________________________________________________ 
   Participants who were recruited Participants who completed 
   for the intervention (n=23)  the intervention (n=19)  
Characteristics __________________________ _______________________ 
      
     n  %    n  %  
________________________________________________________________________ 
 
Race     
White/Caucasian  12  52.2   10  52.6 
Black/African American   9   39.1    7  36.8  
Hispanic     1      4.3     1    5.3    
Native American    1     4.3     1    5.3  
Gender 
Male       15             65.2    12   63.1  
Female     8          34.8                               7                    36.8        
Age in Years 
25-35 years     2                      8.6        2  10.5 
36-45 years     8             34.4                   7             36.8  
46 - 55 years   13             55.9               10  52.8 
________________________________________________________________________ 
A total of 21 participants, 14 males and 7 females, completed session 2 after 
which two participants dropped out. A total of 19 participants (82.6%), 12 males and 7 
females completed both session 3 and 4, therefore completing the entire 
psychoeducational intervention. The demographic information for the 19 participants 
who completed the entire pyschoeducation intervention is also presented in Table 1.  The 
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common psychiatric diagnoses among the participants included major depressive 
disorder, bipolar disorder, schizo-affective spectrum disorders, psychotic disorders, 
anxiety disorders, dissociative somatoform disorders, and substance use disorders.   
After the first session one white female participant voluntarily dropped out stating 
she was no longer interested in the intervention.  The second participant to stop after 
completing session 1 was a White/Caucasian male participant who did not provide a 
reason of why he stopped the project.  The third drop out was a male Black/African 
American participant, who cited transportation issues as the reason that he was unable to 
complete.   The fourth male Black/African American participant stopped participating 
without providing a reason.  His phone went unanswered when contacted to remind him 
of follow-up sessions.  The final characteristics of the participants who completed the 
intervention (n=19) is similar to the original recruited group of participants.  The majority 
of the sample were over the age of 30, similar to the population that receives services at 
the agency.  
Procedures for Recruitment 
Recruitment and Informed Consent 
After receiving approval from Human Research Review Committee Grand Valley 
State University and the Mental Health Agency, participants were recruited by method of 
referrals from case managers at the Agency.  While clients were visiting their case 
managers during the months of April - June 2014, case managers used a recruitment 
script (Appendix E) to recruit potential participants for the intervention.  The script 
introduced the DNP student who was the facilitator of the intervention.  Additionally the 
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script gave an outline of the intervention including the (a) number of sessions, (b) 
duration of the intervention, (c) length of the sessions, (d) measures to be obtained, and 
(e) the purpose of the intervention. The participants who were interested and had been 
referred to participate in the study were provided with an informed consent form 
(Appendix F) after receiving a complete description of the study. The informed consent 
form incorporated language of the Health Insurance Portability and Accountability Act 
(HIPAA) to assure the confidentiality of participant data.  The DNP student obtained the 
informed consent, while the agency supervisor came in immediately afterwards to answer 
questions and concerns from participants and to confirm their understanding of the 
project before signing off on the informed consent. Participants then received a copy of 
the signed informed consent. 
The informed consent included information about the risks, benefits, costs and 
compensation of participation in the project.  Participants were informed that the risks of 
participation in the project included loss of confidentiality.  Participants were notified 
that to ensure that their information is protected, their data were stored in an encrypted 
manner.  The data collection documents were also coded to keep each participant’s data 
together and the list of codes were destroyed when data collection was complete.  
Documents were kept in a locked secure location and will be destroyed three years after 
data collection.  
Project Procedure 
Following consent, initial data were gathered. These consisted of Health- 
Promoting Lifestyle Profile II questionnaire and anthropometric data. The program 
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consisted of four, 45 minute sessions implemented over eight weeks.  The first session 
was primarily educational and planning.  At the start of the second and third session 
participants received supportive follow-up for the previous educational sessions. Progress 
toward the attainment of previous goals was also evaluated.  Additionally, if needed, the 
goals were revised.  Participants also received phone calls as a reminder to attend their 
session.  
After completing each individualized session, participants were verbally reminded 
when they should return for the next session. A phone call reminder was placed to 
participants the day before their session to remind them of their appointment. Some 
participants still had to be called on the day of the intervention if they were late for their 
appointment or if their phones were not answered or working on the previous day.  
Data Collection 
In this project, participants were weighed on the same scale without shoes.  The 
facilitator of the intervention was responsible for obtaining all the anthropometric 
measurements.  In this project, data that were obtained at the first session included 
gender, ethnicity, age, weight, height, blood pressure,pulse, waist size, hip size, 
calculated BMI, waist/hip ratio, intensity of physical activity and fruit and vegetable 
intake. BMI was calculated using height measured at baseline and weight obtained at 
each session. The National Heart Lung and Blood Institute’s BMI was used to categorize 
patients.  A BMI of 18.5-24.9 was categorized as normal, BMI 25-29.9 was considered 
overweight, while a BMI of 30 or greater was considered obese.  Additionally the Health-
Promoting Lifestyle Profile II questionnaire was completed at the first and the last 
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sessions.  During the second, third and fourth sessions, data that were obtained included 
weight, blood pressure, pulse, waist size, hip size, calculated BMI, waist/hip ratio and 
intensity of physical activity.  Secondary information was obtained by reviewing patients’ 
charts to obtain information on patient diagnoses, names and doses of prescribed 
antipsychotic medications.  Data were recorded on a participant data collection sheet 
(Appendix G) during the project.  
Instrument 
The Health-Promoting Lifestyle Profile II (Appendix H) measures behavior 
associated with health-promoting lifestyles.  This instrument was utilized during the first 
and fourth session. The tool has 52 items and the format is a four point response scale: 
never, sometimes, often, and routinely and can be self-administered (Walker & Hill-
Polerecky, 2011).  The instrument is scored by calculating the mean of individual 
responses to all 52 items.  The six subscales scores are similarly obtained by calculating a 
mean of the individual’s response to subscale items.  The questions in the instrument are 
scored as follows: 1=never, 2=sometimes, 3=often and 4=routinely.  The higher the 
score, the greater the improvement.  The Health-Promoting Lifestyle Profile (HPLP) II 
has six subscales which include spiritual growth, interpersonal relations, nutrition, 
physical activity, health responsibility and stress management.  Spiritual growth involves 
the sharing of thoughts and feelings through verbal and nonverbal messages.  The 
interpersonal relations scale involves utilizing communication to achieve a sense of 
intimacy and closeness within meaningful, rather than more casual, relationships with 
others.  Nutrition involves knowledgeable selection and consumption of foods essential 
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for sustenance, health, and well- being.  Physical activity involves regular participation in 
light, moderate, and/or vigorous activity.  Health responsibility involves an active sense 
of accountability for one’s own well-being.  It includes paying attention to one’s own 
health, educating oneself about health, and exercising informed consumerism when 
seeking professional assistance.  Stress management entails the identification and 
mobilization of psychological and physical resources to effectively control or reduce 
tension.  
Walker and Hill-Polerecky (2011) calculated the test-retest reliability of the 
Health-Promoting Lifestyle Profile II as 0.892 after a three week interval.  They reported 
the internal consistency as Cronbach’s alpha 0.943, while the subscales range from 
0.793-0.872.  In this project, the Chronbach’s alphas are displayed in Table 2 and are 
consistent with the prior reliabilities except for two subscales. The nutrition subscale and 
interpersonal relationship subscale obtained at both data collection points were lower 
than reported by the original authors. 
Walker and Hill-Polerecky (2011), performed several validity measures. The 
construct validity was confirmed by factor analysis.  Factor analysis confirmed the six-
dimensional structure of HPLP II.  Further, construct validity of the tool was supported 
by convergence with the Personal Lifestyle Questionnaire (r = 0.678), and by a non-
significant correlation with social desirability.  The HPLP II has significant criterion 
validity with concurrent measures of perceived health status and quality of life (r = 0.269 
-0.491).   
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Table 2  
Chronbach’s Alpha Reliability Scores for the HPLP II 
________________________________________________________________________ 
Scale    Cronbach’s Alpha    Cronbach’s Alpha 
    Pre-intervention   Post-intervention 
    (n=23)     (n=19) 
________________________________________________________________________ 
HPLP 52 item scale   0.921     0.935 
Health responsibility    0.739     0.849  
Physical Activity           0.833     0.743 
Nutrition            0.789      0.448 
Spiritual Growth    0.714     0.739   
Interpersonal Relationship   0.329     0.614         
Stress Management    0.810     0.728  
________________________________________________________________________ 
Intervention 
The project consisted of four individualized, 45 minute psychoeducational 
sessions implemented over eight weeks.  The participants were seen at baseline, day 16-
20, day 34-38 and day 52-56. The participants participated in the intervention between 
the months of April to July 2014.  The facilitator utilized a psychoeducational project 
implementation manual which outlined the session contents. Two sources of information 
were used to develop the pyschoeducation intervention. The first source was the 
Supplemental Nutrition Assistance Program (SNAP) Nutrition Education and Obesity 
Prevention Grant Program, referred to as SNAP-Ed (United States Department of 
Agriculture [USDA], n.d).  SNAP-Ed connection has an online resource center for state 
and local SNAP-Ed providers.  SNAP-Ed is funded by USDA Food and Nutrition 
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Service.   The second source was selected sessions from Eat Smart, Live Strong tool kit.  
The tool kit has been designed for use among able-bodied, 60-74 year olds participating 
in, or eligible for, Food and Nutrition Service (FNS) nutrition assistance programs and is 
consistent with the 2010 Dietary Guidelines for Americans and MyPlate (USDA, 2013).  
The tool kit was adapted for the selected population since it is tailored for low income 
adults.  Furthermore the recommended amount of fruit and vegetable intake for the study 
population was readily adjusted using available online tools such as the SuperTracker 
(USDA, n.d).  
The sessions in the intervention stressed the importance of improving fruit and 
vegetable consumption and physical activity.  The intervention focused on two key 
messages of the 2010 Dietary Guidelines for Americans (USDHHS & USDA, 2010) and 
utilized a variety of behavior-focused strategies to promote these behaviors: (a) increase 
fruit and vegetable intake by making half of your plate fruit and vegetable; (b) balance 
calories with physical activity to sustain a healthy weight; and (c) participate in at least 
30 minutes of physical activity most days of the week.  The sessions were designed to 
motivate and build skills in participants while utilizing self-assessment tools to assist 
them in achieving eating and physical activity goals. 
Session Content 
The first session was titled “Reach Your Goals, Step by Step.”  The purpose of 
the first session was to encourage participants to eat more fruits and vegetables and to 
participate in more physical activity.  During the first session initial data and 
measurements that included gender, ethnicity, age, weight, height, blood pressure, pulse, 
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waist size, hip size, calculated BMI, waist/hip ratio, intensity of physical activity level 
and fruit and vegetable intake were obtained (Appendix G).  Additionally the Health-
Promoting Lifestyle Profile II questionnaire was completed (Appendix H).  Estimated 
calorie needs of each participant was determined using estimated calorie need per day by 
age, gender and physical activity table (Appendix I).  The required amount of cups of 
fruits and vegetables that each participant needed to consume was determined by the 
facilitator using super tracker at every session.  The super tracker is an online tool that 
can help one plan, analyze and track diet and physical activity (USDA, n.d.). 
The psychoeducation module in the first session included the benefits of eating 
fruits and vegetables and participating in at least 30 minutes of moderate-physical activity 
on most days of the week.  During the session each participant identified three benefits of 
eating the recommended amount of cups of fruits and vegetables daily.  Each participant 
also identified three benefits of participating in at least 30 minutes of moderate-physical 
activity on most days of the week.  All participants also listed ways in which they could 
be physically active.  The first session also encouraged behavior change by providing 
participants with an opportunity to set goals and track achievement.  Each participant set 
a personal goal towards eating the recommended cups of fruits and vegetables until the 
next session.  Participants also set a second goal towards participating in 30 minutes of 
moderate-physical activity on most days of the week until the next session.  Each 
participant received a copy of the goal setting handout (Appendix J) to monitor progress 
of fruit and vegetable intake and physical activity levels.  The participants were also 
provided with measuring cups that they could use at home to measure their fruits and 
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vegetables.  Additionally a placemat to help participants monitor their portions was 
provided to participants to take home.  The placemat was illustrated with (a) one cup 
measure of fruits and vegetables, (b) a reminder to engage in physical activity, and (c) my 
plate logo (Appendix K).  The placemat was also used as a cue to reinforce the teachings 
in the intervention.  Samples of one cup measured fruit and vegetables were exhibited to 
participants during the session.  A grant from Kirkhof College of Nursing, Vulnerable 
Population Center of Distinction, supported the purchase of these and other items used 
with the intervention.   
 The second session was titled “Challenges and Solutions.”  At the start of the 
session, the second set of measurements were obtained.   The measurements included 
weight, blood pressure, pulse, waist size, hip size, calculated BMI, waist/hip ratio, 
intensity of physical activity level and fruit and vegetable intake.  The second session was 
designed to offer suggestions that are helpful in adapting eating and physical activity 
behaviors that could assist participants to reach their goals.  The session also encouraged 
behavior change by building participants’ ability to overcome challenges.  The facilitator 
offered supportive follow-up at the beginning of the session to participants by evaluating 
progress towards goal of fruit/vegetable intake and physical activity.  If needed, the 
facilitator also assisted the participant to set new goals.   
The education module in the second session focused on barriers of eating fruits 
and vegetables and participating in at least 30 minutes of moderate-physical activity on 
most days of the week.  Additionally the module discussed solutions to the barriers.  
During the session, participants identified barriers that might prevent them from eating 
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more fruits and vegetables, and engaging in physical activity.  Participants also identified 
three solutions to overcome the challenges they identified that prevented them from 
eating more fruits and vegetables and exercising.  The facilitator offered support and 
necessary resources for overcoming the barriers as well as answered questions that any 
participant had.  Once more, each participant identified three benefits of eating the 
recommended amount of cups of fruits and vegetables daily.  Each participant also 
identified three benefits of participating in at least 30 minutes of moderate-physical 
activity on most days of the week again.  For a second time, participants listed ways in 
which they will be physically active. Again at this session each participant set a personal 
goal towards eating the recommended cups of fruits and vegetables until the next session.  
Participants also set a second goal towards participating in 30 minutes of moderate-
physical activity on most days of the week until the next session.   
  The third session was referred to as “Colorful and Classic Favorites.”  At the 
start of the session measurements that were obtained included weight, blood pressure, 
pulse, waist size, hip size, calculated BMI, waist/hip ratio, intensity of physical activity 
level and fruit and vegetable intake.  The facilitator offered supportive follow-up at the 
beginning of the session to participants by evaluating progress towards goal of 
fruit/vegetable intake and physical activity.  If needed, the facilitator also assisted the 
participant to set new goals.  The education module in the third session consisted of a 
word game (Appendix L, M) and coloring activity (Appendix N).  During the word game 
activity, the participant was able to review the lists of challenges and solutions for eating 
recommended cups of fruits and vegetables each day and participating in physical 
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activity.  The participants were also exposed to hands-on experiences in updating classic 
recipes by adding fruits and vegetables by coloring.  An easy-to-make recipe was also 
provided to help participants make a classic dish at home (Appendix O).  Once more, 
each participant identified three benefits of eating the recommend amount of cups of 
fruits and vegetables daily.  Each participant also identified three benefits of participating 
in at least 30 minutes of moderate-physical activity on most days of the week again.  For 
a third time each participant listed ways in which they can be physically active. Each 
participant set a personal goal towards eating the recommended cups of fruits and 
vegetables until the next session.  Participants also set a second goal towards participating 
in 30 minutes of moderate-physical activity on most days of the week until the next 
session.   
The fourth session was the final session.  The facilitator made a final assessment 
in evaluating participant progress towards goals of fruit/vegetable intake and physical 
activity.  During the session post intervention measurements were obtained.  These 
measurements included weight, blood pressure, pulse, waist size, hip size, calculated 
BMI, waist/hip ratio, intensity of physical activity and fruit and vegetable intake.  The 
Health-Promoting Lifestyle Profile II was also completed for a second time as a post-test.  
During the session the facilitator discussed with the individual participants the goals and 
the progress they made during the intervention.  Participants were also encouraged to 
continue with the lifestyle changes that were emphasized in the intervention. Each 
participant set a personal goal towards eating the recommended cups of fruits and 
vegetables after the completion of the intervention.  Participants also set a second goal 
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towards participating in 30 minutes of moderate-physical activity on most days of the 
week after the completion of the intervention.    
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CHAPTER 5 
RESULTS 
The purpose of this project was to implement a psychoeducational intervention 
that would increase awareness of nutrition and physical activity for adults (aged 18 and 
above) with severe mental illness who are taking antipsychotic medications.  The second 
purpose of the intervention was to determine if the intervention had any effect on weight, 
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting 
lifestyles among this group of adults.   This chapter reports the key study outcomes. The 
chapter also reflects responses from the participants to the Health-Promoting Lifestyle 
Profile II questionnaire. 
Fruit and Vegetable Intake 
          Results show that there was an increase in both fruit and vegetable intake among 
the 19 participants who completed the study (Table 3). The mean of the fruit intake for 
the 19 participants at the start of the program was 8.73 cups/2weeks and 20.31 
cups/2weeks at the end of the program.  A paired t-test found that the increased fruit 
intake was statistically significant p = 0.001 (Table 3). Similarly, a paired sample t-test 
comparing vegetable intake found that increased vegetable intake was statistically 
significant p = 0.001. The vegetable intake was lower at the start of the program (mean= 
15.85 cups/ 2 weeks) than at the end of the program (mean= 38.45 cups/ 2 weeks) among 
the 19 participants (Table 3).  
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Table 3  
 Paired Samples t-Test Results for Health-Related Behavioral Changes Reported for the Prior Two Weeks 
____________________________________________________________________________________________________________ 
HPLP Scale   Group Means  SD  Mean difference        SD         t  df   p  
____________________________________________________________________________________________________________  
Physical Activity Pre             172.10             160.81   -187.90                 225.13             3.63            18 0.002* 
Physical Activity Post             360.00             275.31                     
Vegetable Intake Pre               15.85               10.53                 -22.60                  25.68              3.93            18 0.001*  
Vegetable Intake post    38.45               24.76 
Fruit Intake pre                  8.73                 8.99                  -11.58               12.52              4.02             18  0.001* 
Fruit Post                                      20.31               12.56 
____________________________________________________________________________________________________________ 
Note.* significant p value.
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Physical Activity 
           Results show that there was an increase in time spent in physical activity among 
the 19 participants who completed the study (Table 3). The mean of physical activity 
minutes for the 19 participants at the start of the program was 172.10 minutes/2weeks 
and 360.00 minutes/2 weeks at the end of the program.  Paired sample t-test comparing 
the time spent in physical activity before and after the intervention was significant (p = 
0.002).  
Weight and BMI 
           For the 19 participants who completed the project, the minimum weight at the 
beginning of the intervention was 131 pounds while the maximum weight was 337 
pounds.   Table 4 show the weight characteristics for the 19 participants at the start and 
the end of the program. Result show that overall, 12 (63%) participants who completed 
the program lost weight over the 8 weeks of the intervention.    The range of weight loss 
among these participants was 0.25 to 10 pounds.  One participant maintained the pre 
intervention weight while a total of 6 participants had an increase in their post 
intervention weight.  The mean of the weight for the 19 participants at the start of the 
program was 221.46 pounds and 219.82 pounds at the end of the program. Despite the 
weight loss by some participants, results of paired sample t-test comparing the weight 
before and after the intervention was not significant p value = 0.184 (Table 5). 
       Of the 19 participants who completed the study, three (15.8%) had a normal BMI of 
18.5-24.9, while four (21.5%) participants were overweight with a BMI 25-29.9 at the 
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start of the intervention (Table 6). A total of 12 (63.1%) of the participants had a BMI of 
30 or greater, therefore considered obese. These BMI cut off points are determined by the  
Table 4  
 Weight at the Start and the End of the Intervention 
________________________________________________________________________ 
Participant   Weight  Weight  ΔWeight 
ID    at the start  at the end 
_______________________________________________________________________ 
014    174.75   164.75   -10.00 
012    239.00   231.00    - 8.00 
006    169.25   161.75     -7.50 
023    297.25   291.00     -6.25 
021    140.00   134.00     -6.00 
009    275.00   269.00     -6.00 
011    248.00   243.75     -4.25 
022    258.50   255.00     -3.50 
004    131.00   129.00     -2.00 
018    305.25   303.25     -2.00 
017    197.50   197.00     -0.50 
010    181.50   181.25     -0.25 
020    166.00   166.00      0.00 
007    150.50   151.25    +0.75 
016    239.00   239.75    +0.75 
015    198.25   202.25    +4.00 
008    287.00   291.25    +4.25 
019    337.00   343.25    +6.25 
004    213.00   222.00              + 9.00 
________________________________________________________________________
  
 
77 
Table 5 
Paired Sample t-Test for Biological Variables 
_____________________________________________________________________________________________________________________ 
Item   Mean   SD Mean Difference  SD  t    df  p    
_____________________________________________________________________________________________________________________ 
Weight pre          221.46               60.82                 1.63                        5.15                 1.38  18                 0.184 
Weight post    219.82               61.96  
BMI pre     33.13                 9.27                  0.23                       0.78                 1.31  18                   0.206 
BMI post        32.89                 9.55             
Waist pre                             44.68                 7.37                 0.63                       1.59                 1.73  18                    0.100 
Waist post                             44.04                 7.68 
Hip Pre                              46.94                  6.08                1.38                       1.19                5.04  18              0.0001* 
Hip Post                 45.56                  6.01 
Waist: Hip pre                                 0.95                 0.10                -0.01          0.03             -1.75  18                     0.097 
Waist: Hip post       0.96                 0.10          
Systolic BP pre   124.32               11.93             1.68                               13.75         0.53  18                     0.600     
Systolic BP post  122.63               15.32       
Diastolic BP pre                 81.63                6.18                -0.63                               7.96                    -0.35                  18                       0.733  
Diastolic BP post      82.26                8.84 
Pulse pre                 82.47              15.41                 1.94                              12.05                     0.70   18  0.490 
Pulse post      80.53              10.86 
___________________________________________________________________________________________________________________ 
Note.* significant p value.
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Table  6 able 6  
BMI at the Start and the End of the Intervention  
________________________________________________________________________ 
Participant   BMI   BMI   ΔBMI 
ID    at the start  at the end 
_______________________________________________________________________ 
014    27.37   26.00   -1.37 
012    35.29   34.11   -1.18 
021    22.59   21.63   -0.96 
009    43.07   42.13   -0.94 
023    38.16   37.36   -0.80 
010    26.04   25.33   -0.71 
006    26.51   25.80   -0.71 
011    34.59   33.99   -0.60 
022    34.10   33.64   -0.46 
005    21.80   21.46   -0.34  
018    40.27   40.00   -0.27 
017    32.86   32.78   -0.08 
020    28.49   28.49     0.00 
007    20.99   21.09   +0.10  
016    32.41   32.64   +0.23 
015    31.99   32.51   +0.52 
008    43.63   44.28   +0.65 
019    59.69   60.84   +1.15   
004    29.70   30.96   +1.26 
________________________________________________________________________ 
 
 
 
 
 79 
 
 
American Heart Association (2013).   The mean of the BMI for the 19 participants at the 
start of the program was 33.13, and 32.89 at the end of the program (Table 5).  The paired 
sample t-test comparing BMI before and post intervention also had a non-significant p 
value = 0.206 (Table 5).    
Waist Circumference, Hip Size and Waist/Hip Ratio 
          Waist circumference which is a measure of central adiposity is now considered to 
be a more valid predictor for risks for cardiovascular disease, type 2 diabetes and other 
metabolic risk-related conditions compared to BMI (National Institute of Health [NIH], 
2011).  Waist circumference greater than 35 inches for women and 40 inches for men is 
indicative of increased cardiometabolic risk (Jensen et al., 2013).   A total of six (85.7%) 
out of the seven women and nine (75%) of twelve males who completed the intervention 
were above this cutoff at the start of the intervention (Table 7) indicating the group had 
increased cardiometabolic risk. The mean for the waist circumference for the 19 
participants at the start of the program was 44.68 and 44.05 at the end of the program 
(Table 5).    A paired t-test comparing the waist circumference at the start and the end of 
the intervention was statistically non-significant (p value = 0.184). 
Hip circumference when used in conjunction with waist circumference facilitates 
the measurement of central adiposity.  For the 19 participants who completed the project, 
a paired t-test found that hip size change had a statistically significant p value = 0.0001. 
The hip size was lower at the end, mean=45.56 inches, than at the start of the 
intervention, mean = 46.94 inches (Table 5). 
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Table 7 
Waist Circumference Before and After the Intervention by Gender and Descending 
Change 
________________________________________________________________________ 
Participant  Gender Waist   Waist   ΔWaist 
ID     at the start  at the end                                         
________________________________________________________________________ 
022   male  49.01   45.87   -3.14 
012   male  50.00   47.44   -2.56 
004   male  45.00   47.64   -2.00 
014   male  42.00   40.55   -1.45 
010   male  37.00   35.63   -1.37 
018   male  55.30   54.92   -0.38 
009   male  53.00   52.56   -0.44 
007   male  29.13   29.13     0.00 
016   male  48.62          48.62     0.00 
006   male  40.98   39.57   +1.41 
023   male  48.80   47.83   +0.97 
005   male  34.01   34.84   +0.83 
021   female  32.48   28.74    -3.74 
017   female  46.26   44.09    -2.17 
011   female  45.98   45.47    -0.51  
008   female  55.00   54.92    -0.08 
015   female  46.26   47.64   +1.38 
019   female  48.22   49.41   +1.19 
020   female  41.93   42.04   +0.11 
________________________________________________________________________ 
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           Calculated waist-hip ratio (waist circumference divided by hip circumference) of 
participants is shown in Table 8.  Waist-hip ratio measures body fat distribution and has   
Table 8 
 Waist-Hip Ratio Before and After the Intervention by Gender  
________________________________________________________________________ 
Participant  Gender Ratio    Ratio   ΔRatio 
ID     at the start  at the end                                         
________________________________________________________________________ 
022   male    0.99     0.94   -0.05 
010   male    0.89     0.86    -0.03 
009   male    1.02     1.00    -0.02 
014   male    0.90     0.95   +0.05 
007   male    0.72     0.77   +0.05 
004   male    1.01     1.06   +0.05 
016   male    1.07     1.10   +0.03 
005   male    0.87     0.89   +0.02 
018   male    1.08     1.10   +0.02 
006   male    0.97     0.98   +0.01 
023   male    0.96     0.97   +0.01 
012   male    1.06     1.07   +0.01 
021   female    0.83     0.77    -0.06 
011   female    0.92     0.92     0.00 
017   female    0.99     0.99     0.00 
008   female    1.01     1.06              +0.05 
015   female    1.08     1.11              +0.03 
020   female    0.91     0.94              +0.03 
019   female    0.75     0.79              +0.04 
________________________________________________________________________ 
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been found to be better in determining visceral fat than BMI (Seidell et al., 1989). In 
some studies waist-hip ratio has also been found to be positively associated with 
incidence of myocardial infarction, stroke, and death from all causes in men and women 
after adjusting for BMI (Larrson et al., 1984).  Waist/hip ratio greater than 0.90 cm in 
men and 0.85 cm in women is indicative of increased cardiometabolic risk (USDA, 
1990).  A total of five (71.4%) out of the seven women and eight (66.6%) of twelve 
males who completed the intervention were above this cutoff at the recruitment (Table 8) 
indicating the group had increased cardiometabolic risk. The mean of waist/hip ratio for 
the 19 participants at the start of the intervention was 0.95, and 0.96 at the end of the 
intervention (Table 5).  A paired sample t-test comparing the waist/ hip ratio at the start 
and the end of intervention was statistically non-significant with a p value of 0.97. 
Systolic and Diastolic Blood Pressure 
            A total of three of the nineteen participants who completed the intervention had 
blood pressure greater than 140/90, while two of the nineteen participants had blood 
pressure greater than 130/85 at the start of the intervention.  A blood pressure of 130/85 
or higher is considered a metabolic risk factor (NIH, 2011).  The mean for systolic blood 
pressure for the 19 participants at the start of the program was 124.32 and 122.63 at the 
end of the intervention.  A paired t-test comparing the systolic blood pressure at the start 
and the end of the intervention was statistically non-significant, p value = 0.600 (Table 
5).  The mean for diastolic blood pressure for the 19 participants at the start of the 
program was 81.63 and 82.26 at the end of the program.  Similarly, a paired t-test 
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comparing the diastolic blood pressure at the start and the end of the intervention was 
statistically non-significant, p value = 0.733 (Table 5) 
Pulse 
           The mean for the pulse rate for the 19 participants at the start of the program was 
82.47 and 80.53 at the end of the program (Table 5).    A paired t-test comparing the 
pulse at the start and the end of the intervention was statistically non-significant, p value 
= 0.490 (Table 5). 
  Results for Health-Promoting Lifestyle Profile II 
The pre- and post- Health-Promoting Lifestyle Profile II questionnaire (Appendix 
H) scores were analyzed using paired t-tests.   Results for the paired sample t-test for 
Health-Promoting Lifestyle Profile II are presented in Table 9.  The paired t-test for the 
52-item pre- intervention Lifestyle Profile II and post-intervention Lifestyle Profile II 
was significant (p=0.026).  The paired t-test for pre-intervention Physical Activity and 
post-intervention Physical Activity subscale was also significant (p=0.044).  Finally, the 
paired t-test for pre-intervention Spiritual Growth and post-intervention Spiritual Growth 
subscale was also significant (p = 0.012).  All of these scales increased during the 
intervention.  No other subscales showed a significant change. 
The items on the physical activity subscale include (a) following a planned 
exercise program, (b)  type and time spent in  physical activity, (c)  engaging in physical 
activity as a form  of recreation or daily activities, and (d) checking pulse and reaching 
target heart rate when exercising. The items on spiritual growth include (a) changing in 
positive ways, (b) life having a purpose, (c) looking forward to the future, (d) feeling 
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content with self, (e) working toward long term goals, (f) exposing self to new 
experiences and challenges, (g) finding one’s days interesting, (h) being aware of what is 
important in life, and (i) feeling connected with a greater force.  
Other Findings 
Goal Setting and Participants 
The goals that pertain to fruit and vegetable intake and physical activity for three 
participants who lost the most weight and three who gained the most weight are presented 
in Table 10.  The goals of the participants who lost the most weight during the 
intervention were generally consistent related to increasing the intake of fruits and 
vegetables as well as physical activity.  The majority of the participants who lost weight 
at the end of the intervention indicated that they would engage in at least three days of 30 
minutes or greater of physical activity for at least three days or more each week. Two 
participants who planned to participate in seven days of physical activity after the first 
session, as well as increase their intake of cups of fruits and vegetables, lost 7.5 pounds 
and 10 pounds.  At the end of the intervention, interestingly, the participant who had lost 
10 pounds indicated that he would maintain physical activity at 30 minutes seven days a 
week, but decrease his intake of fruit and vegetable to 1 cup daily.   
The participants who gained the most weight also made relatively consistent goals 
pertaining to their fruit and vegetable intake, and physical activity (Table 10). However, a 
few of the participants also made inconsistent goals. After examining the goal setting of 
all participants the consistency of goal setting had little impact on biological outcomes. 
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Table 9 
Paired Samples t-Test for the Total and Subscales of the Health-Promoting Lifestyle Profile II 
_____________________________________________________________________________________________________________________  
HPLP II Scale    Mean   SD  Mean difference  SD  t  p 
_____________________________________________________________________________________________________________________ 
HPLP II pre    2.498  0.482           -0.233   0.420  -2.426  0.026* 
HPLP II post    2.732  0.502                      
Health responsibility pre  2.495  0.660            0.003   0.638  0.025  0.980 
Health responsibility post  2.492  0.775   
Physical Activity pre          2.143  0.763           -0.322   0.649  -2.164  0.044* 
Physical Activity Post                          2.466  0.658 
Nutrition pre           2.362  0.665          -0.321   0.879  -1.592  0.129 
Nutrition Post     2.684  0.847 
Spiritual Growth pre   2.631  0.565           -0.309      0.446  -2.809  0.012* 
Spiritual Growth Post   2.941  0.553                
Interpersonal Relationship pre  2.820  0.384           -0.185   0.446  -1.812  0.087 
Interpersonal Relationship post  3.005  0.445 
Stress Management Pre   2.485  0.766             -0.264   0.629  -1.784  0.092 
Stress Management Post  2.750  0.640 
____________________________________________________________________________________________________________________ 
Note. * significant p value.
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Table     10 
 
Summary of Goals for Some Participants Who Lost the Most Weight Compared to Those who Gained the Most Weight 
_____________________________________________________________________________________________________________________ 
 
  Session 1   Session 2   Session 3   Session 4____________ 
 
ID  ΔW F V PA  F V PA  F V PA  F  V PA 
_____________________________________________________________________________________________________________________ 
 
014 -10.00 1.5 2 30min. 4d/wk 2 2 30min/7d/wk 2 2 30min/7d/wk 1 1 30min/7d/wk  
012   -8.00 2 3 45min.5d/wk 2 3 30min/5d/wk 2 2 30 min/3d/wk 2 3 30min/3d/wk 
006  -7.50 3 4 30min/5d/wk 3 3 30min/7d/wk 3 3  30min/7d/wk 3 3 30min/7d/wk 
008 +4.25 2 3 15min/5d/wk 3 2 25min/5d/wk 2 3 30min/5d/wk 3 3 30min/7d/wk 
019 +6.25 2 3 30min/3d/wk 1.25 2 30min/3d/wk 1.5 2 30min/3d/wk 1 2 15min/7d/wk 
004 +9.00 2 3.5 30min/5d/wk 2 3.5 30min/5d/wk 2 3.5 30min/3d/wk 2 3.5 30min/3d/wk  
_____________________________________________________________________________________________________________________ 
 
Note.   ΔW= change in weight; F   = daily cups of fruits; V = daily cups of vegetables; PA = physical activity; min = minutes; d/wk= days per 
week.
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Barriers and Solutions to Increasing Fruit and Vegetable Intake 
During the second and third sessions, participants shared with the facilitator the 
barriers to reaching their goals. They then participated in a problem solving exercise to 
find solutions to the barriers that prevented them from meeting their fruit and vegetable 
intake goals.  Table 11 represents a summary of barriers that were shared by participants. 
Stress and depression were identified as affecting the emotional well-being of some 
participants and prevented them from attaining their goals. Other health issues, which 
affected some participants’ ability to meet their fruit and vegetable intake goals, were 
identified as including tooth pain and diarrhea. Some participants indicated that they had 
difficulty affording fruits and vegetables or had run out of their food stamps.    
Access to fruits and vegetables seemed to be a key concern to some participants. 
Some participants who lived in adult foster care (AFC) homes indicated that fruits and 
vegetables were not provided in their living setting. Lack of transportation was 
mentioned by a participant as a barrier that affected the intake.   Lack of support from 
family and friends was also reported as a factor that affected fruit and vegetable intake. 
Lack of storage space was cited by one participant. Some participants mentioned that 
they found it difficult to change their prior behaviors. Busy schedules also affected 
participants’ ability to attain their fruit and vegetable intake goals. 
Participants were also able to find solutions to the barriers that prevented them 
from increasing their fruit and vegetable intake.  This is evident in Table 11 where fewer 
barriers were identified at session 3.   Participants identified relaxation techniques as a 
means of reducing stress. Participants who indicated that their depression affected their 
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goals were able to identify that they would seek assistance immediately from their case 
worker, psychiatrists, or psychologist for depression.   
Table 11 
 
Barriers to Increasing Fruit and Vegetable Intake 
________________________________________________________________________ 
Barrier     Session 2   Session 3                                                 
      n reporting   n reporting 
________________________________________________________________________ 
Lack of time     1     
Dislike of fruit and vegetable   2    2 
Affordability     7    2 
Lack of access     2    1 
Depression     2   
Lack of time     1     
Difficult to change    1 
Lack of transportation    2 
Health Problems    2    1 
Lack of family/friends support  1    1 
Fruit/vegetable going stale   1    1 
Lack of storage space    1 
Craving unhealthy foods   1 
________________________________________________________________________ 
Total number of barriers            24    8 
________________________________________________________________________ 
Participants with dental problems also stated they were going to follow through 
with the dentist or oral surgeon.  One participant, who had reported that a busy schedule 
was a barrier, indicated that packing fruits and vegetables to take along in the car would 
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be a solution. Having a schedule for eating fruits and vegetables was also mentioned as a 
solution that would assist to increase intake.  
One participant indicated that eating fruits and vegetables prior to eating other 
foods would be beneficial. Adding spices to the vegetables was also identified as a 
solution to improving intake. Eating fruits for dessert was identified as a solution that 
could promote fruit intake.   Eating fruits and vegetables consistently was also mentioned 
as one solution that could promote intake.  Since affordability of fruits and vegetables 
was a concern, one participant indicated that he had requested the AFC home owner to 
provide him with fruits and vegetables.  
 Buying fruits and vegetables during sales was also mentioned by participants as 
one method of overcoming the barriers.  Participants also indicated that it would be 
helpful to learn to budget and buy and stock their fruits and vegetables when they had 
food stamps. Buying just enough fruits and vegetables was identified by one participant 
as a solution to preventing the supply from going stale while also addressing the problem 
of inadequate storage space. To counter transportation barriers, participants identified that 
they could walk to the store. Additionally, some participants indicated that they would 
seek assistance from the case managers to provide them with bus tokens in order to have 
transportation means to the grocery store. 
Facilitators of Increasing Fruit and Vegetable Intake 
During the second and third session, participants also shared with the facilitator 
the reasons that had made them successful in increasing their fruit and vegetable intake 
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(Table 12).  Several participants indicated that they had been successful in increasing 
their fruits and vegetable intake because they had free meals at a local feeding center.  
Table 12 
Facilitators of Increase in Fruit and Vegetable Intake 
________________________________________________________________________ 
Facilitator        Session 2      Session 3 
                                                       n reporting      n reporting  
________________________________________________________________________ 
Availability of fruits and vegetables   5    3 
Desire to eat healthy     3    4 
Desire to lose weight      3     
Routinely eats fruits and vegetables   1     
Liking fruit and vegetables    2    5 
Information, goals and resources from the project 5    3 
Adding spices/seasoning to vegetable  1 
Routinely/raised eating fruits and vegetables  1    1  
Motivation      1    1 
Family support         1 
Eliminating unhealthy snacks        1 
Trying new recipes         1 
________________________________________________________________________ 
Total number of facilitators                                   22             20 
________________________________________________________________________ 
One participant stated that his AFC home had started providing fruits and 
vegetables in order for the participant to meet his project goals. Some participants 
attributed their success at increasing fruit and vegetable intake to the desire to eat healthy 
while others wanted to lose weight.  Other participants indicated that they liked eating 
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fruits and vegetables.  Some participants indicated that their success was due to the 
motivation to meet their project goals.  One participant was motivated by the personal 
reason to lose weight as she was participating in a family member’s wedding.  One 
participant indicated that cutting down unhealthy snacks had facilitated him being 
successful in increasing his intake of fruits and vegetables. Adding dressing and 
seasoning to vegetables was cited as a reason that enabled a participant to increase fruit 
and vegetable intake.  Some participants attributed their success in increasing fruit and 
vegetable intake as resulting from the information that they obtained from the 
psychoeducation intervention.  
Barriers and Solutions for Increasing Engagement in Physical Activity 
 During the second and third sessions, participants also shared barriers that had 
prevented them from meeting their physical activity goals.  Following barrier 
identification, they problem-solved to find solutions to the barriers.  Barriers to physical 
activity are represented in Table 13.  Health problems including chronic pain, arthritis 
and neuropathy were identified by some participants to have affected their ability to meet 
their physical activity goals. Bad weather that included cold weather, rain, snow, and heat 
also affected the participants’ ability to meet their physical activity goals. Busy 
schedules, lack of motivation and fatigue were identified by participants as having 
affected their physical activity goals.  One participant was concerned about the safety of 
the environment in which she engaged in physical activity.  
In regards to chronic pain, participants identified the need to engage in physical 
activity when they had no pain. Maintaining activity as tolerated and taking pain 
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medication as directed by their health care providers was also provided as a solution to 
the physical activity barrier.  Participants also identified the need to avoid a sedentary 
lifestyle.  Motivating self to engage in physical activity, and seeking support from and 
exercising with family members were cited as ways of improving engagement in physical 
activity.   
Table 13 
Barriers to Physical Activity 
________________________________________________________________________ 
Barrier      Session 2   Session 3 
                                                    n reporting    n reporting 
________________________________________________________________________ 
Health issues     4     4 
Unfavorable weather    4     2 
Fatigue     2     
Lack of motivation    3 
Lack of time          1 
Safety Concerns    1     1 
________________________________________________________________________ 
Total number of barriers            14                                                          8 
_______________________________________________________________________ 
 
Having a set schedule for physical activity was also mentioned as helpful.  In 
order to overcome the bad weather, participants indicated that they could engage in 
physical activity in the house or postpone activity to a favorable day.  The participant 
who was concerned about safety stated that finding a park with lots of people and also 
focusing on positive thoughts would be helpful. One participant indicated that seeking 
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assistance from the case manager would be instrumental in identification of a discounted 
gym membership. 
Facilitators of Increase in Physical Activity in Participants  
During the second and third session, participants also shared the reasons that had 
made them successful in increasing the time that they participated in physical activity 
(Table 14).   
Table 14 
Facilitators of Engagement in Physical Activity 
_______________________________________________________________________ 
Facilitator     Session 2   Session 3 
                                                    n reporting   n reporting 
________________________________________________________________________ 
Job requires physical activity    2    1 
Lose weight          2 
Daily routine involve physical activity  7    2 
Scheduling physical activity        1 
Desire for healthy lifestyle    4    3 
Motivation      1    1 
Relaxation        2    1 
Project goals      2 
Personal reasoning (wedding)   1 
Enjoys physical activity    3    2 
Family/friends support    2     
Favorable weather     2    4 
________________________________________________________________________ 
Total number of facilitators             26             17 
________________________________________________________________________ 
 
 
 
 
94 
 
Participants indicated that favorable weather conditions increased their ability to 
engage in physical activity. Some participants indicated that health benefits that included 
improvement of arthritis symptoms and stress reduction made them engage in physical 
activity.  Use of music while engaging in physical activity increased the success of one 
participant.  
 Some participants indicated that support from family and friends made them 
successful.  The desire to change and improve overall health was also a motivator for 
some participants.  Some participants indicated that what motivated them to be successful 
in physical activity was their commitment to keep their project goals. Other participants 
stated that the benefits of physical activity that included improvement of their shape, 
muscle strength and reduction of belly fat. Other reasons for success in engaging in 
physical activity included enjoyment that was derived by participants.  Motivation to lose 
weight was also reported by a participant.  One participant reported that he was 
successful in participating in physical activity because he was now his own cheer leader.  
One participant stated he was successful in engaging in physical activity when he was 
well rested.  
Barriers and Facilitators of Weight Loss or Gain in Participants 
  Some of the common themes among the participants who lost weight during the 
intervention emerged related to why they were successful.  They included access to 
availability of fruits and vegetables, (b) desire to lose weight and maintain a healthy body 
weight, (c) commitment to their project goals, (d) increased motivation, and (e) 
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adherence to the teaching from the project. Overall the themes reflect that they were 
eating better and were physically active.  
 Of the participants who gained weight, the indicated key barriers included (a) 
fatigue, (b) bad weather, (c) lack of access to fruit and vegetables, (d) lack of motivation, 
and (e) safety concerns.  It is also notable that some of the participants who gained 
weight had a high baseline weight to begin with. However, there are exceptions, for 
example one participant whose baseline weight was 297.25 pounds was able to lose 6.25 
pounds at the end of the intervention.  Some participants who indicated that they did not 
have barriers when it came to increasing their physical activity as well as intake of fruits 
and vegetables still gained weight.  
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CHAPTER 6 
DISCUSSION 
The purpose of this project was to implement a psychoeducational intervention 
that would increase awareness of nutrition and physical activity for adults (aged 18 and 
above) with severe mental illness who are taking antipsychotic medications.  The second 
purpose of the intervention was to determine if the intervention had any effect on weight, 
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting 
lifestyles among this group of adults.  The objective of this chapter is to discuss the 
nutrition, physical activity and physiological outcomes. Additionally, Health-Promoting 
Lifestyle Profile II questionnaire outcomes are discussed. The strengths and limitations of 
the intervention are presented. In addition, the implications for nursing practice are 
highlighted.  This chapter also includes a discussion of the implications for future study.  
In writing this chapter, the role of the DNP-prepared clinician is also highlighted.  The 
sustainability of the psychoeducational program in the community health clinic is also 
discussed.  
Discussion of Results 
 The need to implement non-pharmacological interventions in the management of 
weight and physical illness through patient education has been supported by various 
meta-analyses and literature.  The literature reviewed in the project supported the use of 
psychoeducation that focuses on nutrition and exercise to manage people in the target 
patient population (Menza et al., 2004).  Vreeland et al. (2010) supported the use of 
similar interventions for promoting healthier lifestyles in people with mental illness.  The 
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importance of psychoeducational interventions as a means of weight management has 
also been supported by literature (Littrell et al., 2003; Loh et al., 2006; Menza et al., 
2004; Wu et al., 2008).  More importantly, the use of structured patient education using 
verbal, written and discussion methods as implemented in this intervention has been 
found to be successful in the targeted population (Fernandez et al., 2006). 
Results from this project indicate that the participants who completed the 
psychoeducational intervention had significant improvement in their intake of fruits and 
vegetables over the eight week time period of the study. Additionally, participants also 
had a significant improvement in the amount of time that they were engaged in physical 
activity over the eight week time period of the study.  The results of the project indicate 
that psychoeducational interventions can have an impact on nutrition and physical 
activity and health promoting behaviors in this patient population and can be successfully 
implemented over an eight week period. These findings are consistent with the current 
literature review. The results from the project demonstrate the value of promoting an 
evidence-based intervention to improve health outcomes in patients with severe mental 
illness who have increased cardiometabolic risk factors. 
A total of 12 participants out of the 19 participants who completed the 
intervention also had a decrease in weight and BMI. The overall total weight loss by the 
group who participated in the intervention was 31 pounds, however the change was not 
statistically significant. Despite the lack of significant change in weight and BMI, the 
change in weight for the successful individuals further improves their health outcomes 
and begins to reduce their individual cardiometabolic risks.   The eight week 
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psychoeducational intervention did not show statistically significant changes in 
participants’ blood pressure, pulse, waist, and waist/hip ratio. However there was a 
statistically significant decrease in the hip size of the participants. The lack of effect on 
physiological outcomes calls for further study.  For example, studies with a longer 
duration would be beneficial to see if these parameters would change. Overall, the 
psychoeducation seems to be a promising intervention that may help modify risk factors 
including obesity, poor nutrition and the lack of physical activity that is prevalent in the 
targeted patient population.  However, follow-up of participants would be beneficial to 
determine whether the benefits are sustainable after the eight week intervention period.  
The total score on the 52 item scale Health-Promoting Lifestyle Profile II 
questionnaire showed significant improvement after the intervention, indicating that the 
intervention had an impact on the participants’ behavior associated with health promoting 
lifestyles.  There was improvement in the spiritual growth subscale indicating that the 
psychoeducation intervention was effective in employing strategies that allowed 
participants to share thoughts and feelings through verbal and nonverbal messages that 
pertained to their health promoting goals and behaviors.  The intervention allowed 
participants to be more goal oriented, more exposed to new experiences and be more 
aware of what was important in their lives as the scale items suggest. Key strategies of 
the intervention that were used included participants completing multiple choice 
questions and verbalizing the benefits of eating fruits and vegetables. Participants also 
wrote down and verbalized their barriers and solutions to increasing fruit and vegetable 
intake, and physical activity. Another activity offered was participation in a word game 
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and coloring activity. More importantly, participants were able to formulate, write down 
and verbalize their project goals at every session.   
There was also improvement on the physical activity scale. This agrees with the 
findings of the study that the participants improved their engagement in regular 
participation in light, moderate and vigorous activity over the eight week study period.  
Other findings in the study indicated that the participants were faced with many 
barriers that affected their project goals. Health problems, financial difficulties, 
transportation, lack of fruit and vegetables, safety issues, and lack of motivation were 
common.  Despite the challenges, these participants with mental illness were engaged in 
mutual goal setting and problem solving that made several participants successful in 
overcoming some of their barriers. In light of the findings of the challenges faced by this 
population, the overall implication is that policy makers and the administrators of the 
mental health agency need to pay attention to these barriers when it comes to future 
program planning.    
The completion rate of 19 participants out of the original 23 participants, is also a 
key finding. This is an indication that individuals with severe mental illness can be 
engaged and participate successfully in an intervention.  Four participants did not 
complete the intervention. One indicated that she was no longer interested in the 
intervention. Two male participants did not provide a reason for dropping out. Another 
male participant who dropped out indicated that he had problems with transportation.  
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Community Mental Health Clinic Environment and Interprofessional Team  
It was imperative to assess the project site in order to understand current efforts 
related to health, nutrition and exercise teaching.  The project site is designated as a 
Community Case Management site.  The Community Case Management is one of the 
divisions of a larger mental health organization in a mid-western city in the United States.  
Community Case Management is one of the providers for the community behavioral 
health authority in the county where it is located.  The clients who are served by the 
Community Case Management are referred from the community behavioral health 
authority after eligibility for Case Management services has been determined.   
The Community Case Management agency is a medically necessary service 
designed to assist individuals who have a serious mental illness or co-occurring disorder 
(mental health, medical health, or substance use) to develop and implement strategies for 
obtaining strength-based and individualized services and supports.  These are identified 
through a person-centered planning process.   
The case managers at Community Case Management assist the clients in applying 
for benefits such as social security and government assistance such as Medicaid.  Clients 
also receive assistance in finding resources like housing and access to substance abuse 
recovery programs.  Mental health clients receive medical services from an onsite 
integrated medical clinic.  The staffing of the integrated clinic consists of one onsite 
psychiatrist, one telepsychiatrist, and a psychiatric nurse practitioner.  The clinic employs 
three registered nurses; one is full time while two are part time.  
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Efforts to Address Chronic Conditions at the Project Site 
The project site has identified physical health and wellness as a desired goal for 
the clients it serves.  The site provides wellness groups that are conducted by case 
managers to emphasize preventive care and management of chronic health conditions.  
These wellness groups could focus more regularly on diet and physical activity.  In order 
to address wellness needs for the population, the project study location uses enhanced 
primary care coordination services.  Clients with cardiovascular diseases, asthma, COPD, 
obesity and diabetes are referred to primary care services to ensure a continuum of care.  
Role of Case Managers in Addressing Chronic Conditions 
There are a total of about ten case managers who are both Bachelors and Master’s 
level social work clinical staff.  The screening for enhanced service starts with the initial 
psychosocial assessment that is completed by the case workers during admission.  The 
coordination of primary care is provided to all Case Management clients.  The role of the 
case managers in terms of health promotion is to screen for co-morbid conditions.  The 
case managers also assist the clients in becoming established with a primary care 
physician.  Additionally, they coordinate information between Community Case 
Management and primary care offices.  They are required by organizational policy to set 
a minimum of one goal addressing general health/wellness with the client.  The site has a 
list of health clinics, which was created by a registered nurse, where the case managers 
can refer the clients.  The clients are referred to clinics that provide care to uninsured 
patients or charge a flat rate.  The clients can also be referred to medical clinics that offer 
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financial assistance to qualifying patients.  The case managers are required to document 
contacts with the primary care providers in case files.  
 The role of the case managers is to coordinate the services of the clients.  Since 
they see the clients more frequently than the medical staff, their role in health promotion 
is crucial.  The case workers should be well trained and provided with adequate resources 
in order to play a key role in the health promotion of the clients.  However, because the 
case managers do not have a medical background it is necessary for the organization to 
establish workshops and health education resources that will enhance their knowledge 
and skills.  
 Role of Registered Nurses in Addressing Chronic Conditions 
The registered nurses (RNs) are based in the Integrated Medical Clinic.  They are 
responsible for the patient assistance program.  They provide support to the psychiatrist 
when clients have appointments for a psychiatric visit.  They also provide triage services 
by being available for questions.  Additionally, RNs review labs and facilitate follow up 
with the psychiatrists or primary care physician as appropriate.  They are responsible for 
obtaining vital signs and reporting to the psychiatrist during office visits.  The RNs are 
responsible for performing nursing assessments.  They provide health education in 
telephone or face-to-face encounters during appointments or walk-ins.  Additionally, they 
maintain contact with the primary care doctor to coordinate treatment plans.  The RNs are 
also available for case consultation with the case managers. 
The Psychiatric Nurse Practitioner is responsible for management of clients 
during their visit to the Integrated Medical Clinic.  Additional duties include ordering 
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labs related to psychiatric medications or conditions.  The Psychiatric Nurse Practitioner 
is also responsible for recommending clients who need referrals to primary care. The 
Psychiatric Nurse Practitioner could expand the role by implementing standards of care 
for managing metabolic syndrome and diabetes associated with psychiatric medications.  
 While the current role of the RNs focuses on the management of mental health 
conditions, expanding the role to screening for comorbid conditions would be more 
beneficial to the organization’s clients. In an expanded role, the RNs could provide 
information and support for areas of health, nutrition, and exercise. They are well 
prepared for this role and possess the required skills.  The RNs and the Psychiatric Nurse 
Practitioner are able to use models like the Health Promotion Model (HPM) to entrench a 
health promotion initiative in the organization.  The use of a manualized 
psychoeducational intervention for diet and physical activity could be easily 
implemented.  
Role of Peer Support Specialist in Addressing Chronic Conditions 
 The peer support specialists help consumers with their identified self-
management strategies.  Additional duties include assisting the consumer with decision 
making and community linkages.  The peer support specialist is responsible for 
supporting self-management approaches, therefore, another key role could include health, 
nutrition and exercise teaching in conjunction with the health care providers. 
Role of the Psychiatrist 
The psychiatrist role is to diagnose and treat mental illness, including addiction 
and substance use.  The psychiatrist also refers patients appropriately to primary care 
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physicians and other specialists as deemed appropriate.  At the project site, 
pharmacological management for overweight and obesity is not a common a practice.  
However, reviewing and changing medications in the case that a client is gaining weight 
from an antipsychotic medication are common interventions.  The integration of the 
psychoeducation intervention would therefore be beneficial as a means of managing 
clients who are at risk for overweight and obesity.  The psychiatrist could also support the 
implementation of standards of care related to metabolic syndrome and diabetes 
associated with psychiatric medications. 
Integrating the Intervention at the Study Site 
It is important to understand the possibility of successfully integrating the 
intervention at the project site.  The facilitator could offer the organization a plan that 
addresses the barriers and facilitators that were identified during the intervention. The 
facilitator could also suggest next steps to implementation which may include (a) staff 
training, (b) use of the psychoeducational manual, and (c) the possibility of entrenching 
the intervention in the electronic health record or intranet of the institution as an 
educational module for case managers, RNs, peer support specialists and as a tool to 
educate the clients in the form of a presentation, such as Power Point.  
The inexpensive nature of the intervention may make it attractive for the mental 
health agency. The implementation of this intervention was supported by a grant from 
Kirkhof College of Nursing, Vulnerable Population Center of Distinction.  Table 15 
represents the expended funds for supplies for the psychoeducation intervention.   In 
addition to the money spent, the time spent by the facilitator to meet with the participants 
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should be considered.  Each participant who completed the intervention met with the 
facilitator for four, 45 minutes sessions during the 8 week period. Obviously, the per 
patient time would increase as on-going support beyond eight weeks is included. Once 
started, this support could be in the form of individual or group support or both, 
depending on efficiency needs and what is required to sustain individual outcomes.  
Table 15 
 
Project Costs 
________________________________________________________________________ 
Item     Price/Unit   Total Cost 
_______________________________________________________________________ 
25 measuring cups    $2.97        $78.71 
25 canvas tote bags    $1.99       $52.73 
25 placemats     $5.00               $125.00 
2 bags of Apples    $4.00            $8.00 
12 packets, mixed vegetables   $2.00         $24.00 
________________________________________________________________________ 
Total Cost                    $288.44 
________________________________________________________________________ 
Usefulness of Health Promotion Model and Chronic Care Model 
These models served to facilitate a collaborative interaction between the 
facilitator and the participants.  The HPM also provided the facilitator a conceptual 
framework for the delivery of the intervention.  Furthermore the model was useful in 
providing a framework to assess the health-promoting behavior of participants prior to 
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and after the psychoeducational intervention.  Health promotion is the foundation of 
prevention and management of chronic illness.  Since the goal of this project was to assist 
the participants to change their behaviors and achieve desired improvement of their 
health risks by maintaining healthy lifestyle behaviors, the HPM supported the design 
and the delivery of the psychoeducation intervention.  Additionally, the HPM was the 
appropriate model to explain the results of the psychoeducation intervention. While 
physiologic measures failed to show significant change (except for hip size), the goal 
setting process resulted in a significant change of health behaviors.  
The CCM provided a conceptual framework to explore the complexities of 
implementing a psychoeducational intervention project in a Community Mental Health 
Clinic that provides care to clients with chronic mental illness. The success of the 
delivery of the psychoeducation intervention was supported by the CCM model. The 
CCM model could be used as a framework to sustain this type of program in the future 
for this organization. The CCM model supports the use of evidence-based practice 
through a collaborative approach to care delivery that includes collaboration with the 
client and an interdisciplinary team.  The CCM provided a framework to the facilitator to 
identify resources to enhance the implementation of the intervention.  The CCM further 
enhanced the formation of a partnership with participants during the implementation of 
the intervention.  More importantly, the CCM facilitated the assessment of the 
organization with the goal of developing a plan for successful project implementation and 
future sustainability.  The CCM further supported the key principle of chronic disease 
management. The need to complement an engaged and committed patient with an 
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informed care team is fundamental to effectively manage obesity and associated 
cardiometabolic risk factors. The organization can use the CCM to plan and implement a 
similar program for their clients by supporting the use of evidence-based education 
interventions when providing client education. Training of the registered nurses (RNs) 
who have the required health knowledge to offer the psychoeducation program while 
having the case managers offer supported follow up to the clientele is one feasible way of 
implementing and sustaining the intervention. 
Strengths of the Project 
This study has several strengths.  One strength is that it was theory driven. Moran, 
Burson, and Conrad (2014) propose that the intervention in the scholarly project should 
be directed by the theoretical framework. In this project the Health Promotion Model and 
Chronic Care Model were used as the theoretical frameworks. More importantly, this 
study provided a great opportunity for interdisciplinary collaboration in the community 
mental health clinic setting. Strength for the intervention is further derived from multiple 
clinical guidelines that address the management of chronic illnesses in the United States 
of America.   The simplicity and measurements of key outcomes is another strength of 
the intervention.   Since the intervention was conducted by one facilitator there was 
consistency in the application of the intervention and outcomes measures. The 
participants in the project were also from diverse ethnic backgrounds and age groups. 
They were representative of the clientele served in the Case Management caseload. The 
intervention utilized various strategies including phone call reminders to retain study 
participants. The participants were provided with tools that reinforced the teaching of the 
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intervention like the measuring cup and placemats. The use of strategies like reviewing 
previous sessions also reinforced the educational content. The clients who participated 
were motivated to engage in the educational intervention.  Finally, the grant received 
from Kirkhof College of Nursing, Vulnerable Population Center of Distinction, was a 
validation of the importance of addressing health outcomes of patients with severe mental 
illness.  
Limitations of the Project 
The limitations of the current project include the small sample size (n=19) and 
convenience sample of participants. This affects its generalizability.  Despite this, it does 
provide some support for the use of this type of intervention in this type of setting.  In 
addition, with the relatively short implementation period, it is impossible to determine 
whether the benefits would be improved and sustained over a longer time. The self-report 
approach in obtaining data for the Health-Promoting Lifestyle Profile II questionnaire, 
reported fruit intake, vegetable intake, and physical activity level was a threat regarding 
the accuracy of the data. Polit and Beck (2008) indicate that self-report questionnaires are 
subject to possible threats, for example response bias or social desirability. Reliability 
related to standardized procedures for obtaining biological measurements is also a study 
limitation.  
Implications for Future Intervention Implementation 
The current project utilized a small sample size. Future recommendations include 
using a larger sample.  The time frame for the study was also short and included only four 
sessions. In designing a future study, a longer time frame and more sessions would be 
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important. There was no opportunity for a longer period of follow-up after the 
intervention.  Future projects or actual interventions should incorporate long term follow-
up for participants to ascertain whether the benefits are sustained.  Barriers and 
challenges that face patients with mental illness should be considered and addressed 
while conducting similar interventions. Clients with severe mental illness can be engaged 
with supported follow up which in turn may lead to their being successful in achieving 
goals for healthy nutrition and engaging in physical activity. 
Whether this type of intervention is studied further or implemented in a site such 
as the Case Managements agency, several conclusions are evident from this project. 
Clients are capable of identifying health related goals that can be successfully obtained 
with appropriate education, facilitation, and support. The success of this brief 
intervention suggests benefits for a longer-term intervention.  The roles of the 
interdisciplinary team can be broadened to support evidence-based interventions and 
standards of care for this at-risk population.  Finally, the role of the DNP prepared nurse 
could be vital to implementing and sustaining system changes that enhance the lives of 
this vulnerable population.  The overall implication is the need to implement and 
document the outcomes of nurse-led interprofessional practice teams to patient outcomes. 
Barriers and Facilitators of Integrating the Intervention 
Apparent barriers to the integration of the proposed intervention include staff, 
time, knowledge and cost.  The staff may be resistant to change what is needed to 
entrench the proposed intervention.  Lack of time for additional duties may be a potential 
barrier to the staff employed by the organization.  Some staff including Case Managers 
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may cite lack of knowledge and skills to implement the proposed interventions.  To the 
organization, the integration of the proposed intervention may require some restructuring 
of the staff duties or addition of staff members including an RN.  The organization may 
consider this as time consuming and costly. 
The organization and all staff members can be effective as facilitators of the 
proposed intervention.  The organization can be a key facilitator of the integration of the 
proposed intervention.  With the passage of the Affordable Care Act (ACA) it is 
necessary for the organization to transform the health care delivery system for improved 
patient outcomes in the management of chronic conditions. Currently the organization 
has a Behavioral Health Care Pilot program whereby clients are screened and assessed to 
determine if they have higher primary care at-risk conditions to facilitate enhanced 
primary care coordination services.  Furthermore provision of comprehensive coordinated 
care improves patient outcomes and decreases health care costs.  
 RNs in the organization are well trained in health promotion and client education 
and can facilitate the integration of the proposed intervention after receiving the 
necessary training.  They can also collaborate with the case managers by providing in-
services to educate the case managers on the implementation of the intervention.  The 
lead case manager can be educated on the intervention and be responsible for educating 
new case managers on how to implement the intervention.  All case managers need to be 
facilitators in the integration of the intervention since they are responsible for providing 
health and wellness education to the clients and for identifying one physical health 
related goal.  They can facilitate the integration of the proposed intervention by 
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recommending it as a resource that would be beneficial in their daily role.  The 
Psychiatrists and Psychiatric Nurse Practitioner who are the key health care providers can 
facilitate the implementation of the intervention by recommending that patients who are 
overweight or obese or who are receiving psychiatric medications that carry these risks 
be referred for the nutrition and physical activity education by the Case Managers, RNs 
and Peer Support Specialist using the proposed intervention.  In conclusion, the presence 
of an interprofessional team, with various levels of expertise within this organization 
provides it with a great ability to entrench the psychoeducation intervention.  
Doctor of Nursing Practice (DNP) Roles 
Several significant roles associated with the Doctor of Nursing Practice (DNP) 
degree were exemplified by the facilitator of this project. With the introduction of the 
Doctor of Nursing Practice (DNP) degree, the DNP prepared clinician should be prepared 
to contribute significantly to the practice environment by engaging in translation of 
evidence-based practice. Furthermore, DNP prepared clinicians are focused on clinical 
practice at the highest standard level of practice (American Association of Colleges of 
Nursing [AACN], 2004). According to the AACN, one role of the DNP prepared advance 
practice nurse is to become an innovative leader in the transformation of the current 
health care system.  Furthermore, Moran et al. (2014) indicate that work that is done in 
relation to improving patients and healthcare systems is increasingly viewed as important 
in contributing to knowledge that can be amassed and shared to produce further 
improvements. The Essentials of DNP education (AACN, 2006) identify enhancements 
to the advanced practice nurse’s knowledge and skill set. Additionally, Moran et al. 
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support the identification of the specific essentials that are demonstrated in the project to 
confirm evidence of doctoral-level work. 
Essential I is the Scientific Underpinnings for Practice which was demonstrated in 
this project. The facilitator integrated nursing science with information from the mental 
health organization. To improve participants’ outcomes, the psychoeducation intervention 
was supported by nursing theory, a theory from a different discipline, and from published 
literature.  
Essential II, which is Organizational and Systems Leadership for Quality 
Improvement and Systems Thinking, was also demonstrated.  According to AACN 
(2006), DNP graduates should display expertise in assessing organizations, identifying 
system issues, and facilitating organization wide changes in practice delivery.  While 
developing and implementing this intervention, the investigator was interested in 
approaches that met the current and future needs of the target patient population and the 
organization that served them.  
The investigator also demonstrated Essential III, which is Clinical Scholarship 
and Analytical Methods for Evidence-Based Practice.  Existing literature was evaluated 
to support the intervention. Additionally, the intervention involved systematic evaluation 
of outcomes of the participants in the mental health agency.  
Another essential that was addressed in the intervention was Essential IV, 
Information Systems/Technology and Patient Care Technology for the Improvement and 
Transformation of Health Care. Supertracker, an online tool, was selected and utilized 
during the intervention to recommend fruit and vegetable intake among participants.  
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Data management and incorporating agency requirements for the use of electronic health 
records and confidential personal information also used information technology.  
Essential V is Health Care Policy for Advocacy in Health Care. Providing an 
intervention that was based on scientific knowledge to a target population that could 
benefit was part of this project. It is important to provide quality care that is responsive to 
vulnerable populations in order to ensure equity in improved health outcomes. 
Interprofessional Collaboration for Improving Patient and Population Health 
Outcomes, Essential VI, was also part of this project.  The investigator collaborated with 
other members of the organization including the team leader and case managers to 
enhance the success of the intervention. The investigator analyzed how organizational 
and professional roles might be redesigned to implement this type of intervention in the 
future.  
Essential VII is Clinical Prevention and Population Health for Improving the 
Nation’s Health and is also important for the DNP graduates.  While implementing this 
intervention the investigator participated in health promotion and risk reduction activity. 
Additionally, the evaluation and interpretation of the current project data may influence 
methods that can improve our nation’s health.  
Finally, Essential VIII is the Advanced Nursing Practice which was clearly 
demonstrated by the investigator. While implementing this intervention the investigator 
incorporated a psychoeducation approach which is supported by the literature in 
managing lifestyle and medications in the target population. The investigator formed 
partnerships with participants as well as agency staff with the goal of improving patient 
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outcomes. The process also involved the development of clinical decision making skills 
and critical thinking. Evaluation of evidence-based care was also an advance nursing 
practice competency that was utilized while developing the intervention.  
Conclusion 
 Clients with severe mental illness have increased cardiometabolic risk factors. 
Individual lifestyle choices that include unhealthy diet and inactivity are prevalent in this 
population. Psychotropic medications also have an impact on physical health problems of 
patients with severe mental illness. DNP prepared clinicians can be at the forefront of  
implementing  interventions that decrease risk factors by engaging patients in 
psychoeducational interventions.  Changing behaviors or maintaining healthy lifestyles is 
difficult for patients with severe mental illness. The outcome of this intervention revealed 
how a DNP educated clinician may implement an intervention to effectively educate 
patients with severe mental illness on the need to modify their increased cardiometabolic 
risk. Additionally, providing clients with simple tools that might contribute to success 
like measuring cups or placemats that reinforce educational content, is another valuable 
consideration. Individual goal setting and supported follow-up utilized by the facilitator 
while conducting the intervention would be worthwhile to consider for this and similar 
agencies serving this clientele.   
Finally, the organization can consider this project as one feasible way of 
implementing a psychoeducation intervention.  Using the CCM model to develop training 
of the registered nurses (RNs) who have the required health knowledge to offer the 
psychoeducation program and the case managers to offer supported follow up to the 
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clients is a feasible way of implementing and sustaining this type of intervention.  The 
feasibility of this intervention can be further enhanced by incorporating modules in the 
EHR, using existing online programs like SuperTracker, and creating a standardized 
workbook for implementation.  The CCM model and the AACN Essentials for DNP 
education support the full engagement of clients with a multi-disciplinary team to achieve 
sound health care goals.  
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from:  Nola Pender <npender@umich.edu>  
to:  Alice Mwanda <mwandaa@mail.gvsu.edu> 
date:  Mon, Feb 25, 2013 at 9:20 AM 
subject:  Re: Permission to use the health promotion theory diagram 
 
Dear Alice: 
 
You have my permission to use the Health Promotion Model in your work and to reprint 
a diagram of the Health Promotion Model in your proposal and written dissertation.  I 
wish you success with your academic work.   
 
To Your Health, 
 
Nola Pender 
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Chronic Care Model  
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Figure 2. Chronic Care Model. Reprinted from “Chronic Disease Management: What Will It Take 
to Improve Care for Chronic Illness?” E. H Wagner, 1998, Effective Clinical Practice, 1998, 
Vol1, Reprinted with permission from American College of Physicians (See Appendix P). 
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Pine Rest Christian Mental Health Services Approval 
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RECRUITMENT SCRIPT 
February 25, 2014 
Dear ______________________, 
During the Winter/Spring 2014, you will have the chance to be part of a special 
project led by a Family Nurse Practitioner, who is a Doctor of Nursing Practice (DNP) 
intern.  
The aim of the project is to improve your health promoting lifestyle and have a 
positive effect on your physical health including weight, BMI, blood pressure and waist 
circumference.  If you choose to be part of this project you will be able to meet with the 
project leader for four 45 minutes individualized sessions (visit). 
Whatever you share with the project leader as part of participating in this project, 
will not be shared outside the Clinic in any way that connects the information to you.  If 
you have any concerns or questions about being part of this project, the project leader 
will be happy to speak with you.  
Thank you! 
 
Alice Mwanda, MSN, FNP, RN 
Doctor of Nursing Practice Intern and Project Leader 
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CONSENT TO TAKE PART IN A PROJECT AND 
AUTHORIZATION TO DISCLOSE HEATH INFORMATION  
Project Title: The Effectiveness of a Psychoeducational Intervention on Health 
Promoting Behaviors and Physical Health of Adult Patients (18 and over) on 
Antipsychotic Medications 
 
Principal Investigator (s):    Alice O. Mwanda, MSN, FNP, RN  
                                                Doctor of Nursing Practice Student 
               Cook DeVos Center for Health Sciences, 
Kirkhof College of Nursing, Grand Valley State University 
301 Michigan St. NE, Grand Rapids, MI 49503-3314,  
Phone (269) 532 9288 
              
Andrea Bostrom, Ph.D., PMHCNS-BC, 
Professor of Nursing and Dissertation Chair  
Cook DeVos Center for Health Sciences, 
Kirkhof College of Nursing, Grand Valley State University 
301 Michigan St. NE, Grand Rapids, MI 49503-3314,  
Phone (616) 331 7172 
 
Jeffrey Madigan, MA, LPC 
Team Lead, Case Management Services  
Pine Rest Christian Mental Health Services  
300 68th ST. SE, Grand Rapids, MI 49501  
Phone (616) 281-6363 ext. 2902  
 
Project Location:   Community Case Management Services 
Pine Rest Christian Mental Health Services  
300 68th St. SE,  
Grand Rapids, MI 49501 
 
 You are being asked to participate in a project study.  In order to decide whether or not 
you should agree to be part of this project, you should receive enough information about 
its procedures, risks and benefits to make a judgment. This process is called informed 
consent. This consent form gives detailed information about the project.  Your 
participation is totally voluntary. If you wish to participate in this project you will be 
asked to sign this form. 
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Description of the project 
The purpose of this project is to learn more about the effectiveness of a 
psychoeducational intervention on health promoting behaviors and physical health among 
persons on antipsychotic medications.  You were referred for the project by your case 
manager.  To participate, you must be at least 18 years old and taking at least taking one 
antipsychotic medication.   
Project Procedures 
If you decide to take part in this project,  
1. You will be asked to attend four sessions (visits), lasting 45 minutes over eight 
weeks. 
2. Your medical record will also be reviewed to obtain information on your mental 
health diagnosis and names and doses of your prescribed medications.  
3. During your first meeting or the informational session with the project leader, 
you will be asked to provide information about your gender, ethnicity and age.  
The project leader will obtain measurements of your weight, height, blood 
pressure, pulse, waist and hip size.  She will also calculate your BMI and 
waist/hip ratio.  The project leader will also ask you to complete a 52 item 
questionnaire on your health promoting lifestyle that will take about 20 to 30 
minutes during the first and the last session. 
4. During the four sessions, the project leader will facilitate an individualized 
educational intervention as well as provide you with supported follow-up with 
the aim of establishing your goals for diet and exercise.  Additionally the 
intervention is aimed at assisting you improve your physical health and reduce 
your weight.  The sessions in the intervention will stress the importance of 
improving fruit and vegetable consumption and physical activity.  The sessions 
have been designed to motivate and build your skills using simple tools that will 
assist you to achieve your nutrition and physical activity goals.  
5. During the second, third and fourth sessions, measurements of your weight, 
height, blood pressure, pulse, waist and hip size will be obtained again.  The 
leader will also calculate your BMI and waist/hip ratio again.  This information 
will be shared with you in writing and with your case manager with your 
permission.  
6. In order to protect your right to have your personal information kept private, 
whatever you share with the project leader will not be shared outside of the 
Clinic in any way that connects the information to you.  The data collection 
documents will be coded to keep them together during the project.  At the 
completion of the project the code list will be destroyed.   
7. Your protected health information (PHI) will not be taken off site. A hard copy 
“source” documents (data collection tools) will be kept in a locked file at Pine 
Rest Case Management. Electronic data will be securely stored in Sharepoint 
after being entered from the hard copy source documents into a spreadsheet - 
this data will be de-identified. Your de-identified data will be downloaded onto a 
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password protected USB prior to being taken to GVSU. A separate master list 
linking your name to your assigned study ID will also be kept. Electronic copies 
of approved protocol, informed consent and data collection tools will also be 
kept in share point.  
8. The facilitator of the project will not be given full access to your chart. Jeffrey 
Madigan can pull the data needed for the project (psychiatric diagnosis and 
medication information) or the facilitator will only be granted access to this 
information.  
 
9. Alice O. Mwanda will obtain the informed consent, Jeffrey Madigan will come 
in immediately afterwards to answer  questions/concerns you may have and to 
confirm your understanding and then sign off on the informed consent. As a 
participant, you will receive a copy of the signed informed consent. 
 
Voluntary Participation and Withdrawal 
Participation in the project is completely voluntary and you may withdraw anytime 
without penalty.  Before agreeing to participate, you may discuss it with someone who is 
not associated with this project.  If you decide to take part in the project and later change 
your mind, you may withdraw or discontinue participation at any time, as well.  
 
Whatever you decide, you will not be penalized or lose any benefits to which you are 
otherwise entitled nor will your decision have any effect on your current or future 
relationship with Pine Rest or affiliated health care provider. Formal withdrawal of your 
consent to participation in this project can be done by notifying Alice O. Mwanda, Dr. 
Andrea Bostrom or Jeff Madigan.  Their contact information is located on the first page 
of this informed consent document.  
 
The project staff can also withdraw you from the project without your consent, if needed.  
The following are some examples why this would happen:  
1. You are unable to comply with or complete the project procedures within the 
outlined project schedule.  
2. Project staff decides that participation is not in your best interest.  
3.  The project is stopped.  
 
Any project information or data recorded resulting from your participation in this project 
prior to the time of withdrawal may continue to be used and disclosed by the project staff 
for the project purposes described. 
 
 
 
Risks or Discomforts of this Project 
 
There may be some minimal risk or discomfort to you as a project participant:  
1. You may feel inconvenienced by the questionnaires or distressed by being asked 
questions that may be uncomfortable for you. You are encouraged to speak with 
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your treatment team about any discomfort, anxiousness or distress you may 
experience. Remember, you may take a break at any time or even stop project 
participation, if needed.  
2. There is a risk of a breach of confidentiality (privacy), although there are many 
safeguards in place to prevent this which are explained later in this consent 
document. To minimize this risk data will be coded during the project.  At the 
completion of the project the code list will be destroyed.  
 
Benefits of this Project 
 
Participation in this project may be a benefit to your health promoting behaviors 
including dietary and physical activity habits.  The participation may also lead to an 
improvement of your physical health.  Because this is an evidence-based research 
translation project the outcomes for individual participants cannot be predicted in 
advance. There may be no benefit to you from participating.  
 
Alternative Procedures 
 
If you do not want to be part of the project, you may choose not to participate and will 
continue to receive the same treatment in the agency.  
 
Costs and Compensation for Project Participation  
 
Neither you nor any third party insurance provider will be billed for project-related 
procedures. No monetary compensation will be given to you for your participation.  
 
Confidentiality and Access to Identifiable Information  
 
Although we cannot guarantee absolute confidentiality and privacy, any information 
about you obtained from this project will be kept as private as possible to the maximum 
extent required by law. However, during your participation, if you indicate risk of 
possible harm to yourself or others, your doctor and/or clinician will be notified.  
 
In order to keep your health information private, you will be assigned a project number 
that will be used instead of your name to code project documents pertaining to your 
participation in the project.  The data collected and analyzed will be indicated by this 
project number only.  A master key linking your name to your project code will be 
maintained separately from your project file in a secure location.  Your project file will 
be stored in a locked file cabinet. Only authorized project personnel will have access to 
these records. The investigators may continue to use, for the purposes described above, 
identifiable information related to your participation for the duration of the project.  
 
You have the right to see and get a copy of your project records for as long as the 
investigator has this information; however, you might not be able to review or receive 
some of the records until after the project has been completed.  
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Project related monitoring, audits and inspections by members of the Grand Valley State 
University Human Research Review Committee and other regulatory authorities will be 
permitted as required.  Additionally, the investigators may be required to release 
identifiable information from your project record in response to an order from a court of 
law. 
 
For data analysis purposes, all project data collected will be sent in a secure manner to 
the Grand Valley State University project staff in Grand Rapids, MI using an encrypted 
USB drive.  Data sent to Grand Valley State University will only be identified by your 
unique project number and will not contain personal identifiers (e.g., name, address, 
social security number). If information from this project is published or presented at 
scientific meetings, your name and other personal information will not be used. 
Questions and Concerns 
If you have any questions or concerns about this project, please contact Alice O. 
Mwanda, Dr. Andrea Bostrom or Jeffrey Madigan.  Their contact information is listed on 
the first page of this document. 
 
If you have any questions or concerns about your rights as a participant in this project, 
please direct them to: 
                   
Human Research and Review Committee 
Grand Valley State University 
301C DeVos Center 
401 Fulton Street 
Grand Rapids, MI 49504 U.S.A 
Phone: 616-331-3197 
Email:  hrrc@gvsu.edu 
 
HIPAA Authorization 
 
As part of this project, you are being asked to release your health information. The Health 
Insurance Portability and Accountability Act (HIPAA) permits a hospital or doctor’s 
office to use or release protected health information (PHI) for the purposes of treatment, 
payment or health care operations. A HIPAA authorization gives permission from you to 
use or release PHI for project purposes, and is in addition to your consent to participate in 
this project. 
 
In working with the sponsor, the investigator, Alice O. Mwanda, will use and 
share personal health information about you. This is information about your 
health that may also include your name, address, telephone number or other facts 
that could identify the health information as yours. This includes information in 
your medical record and information created or collected during the project. This 
information may include your medical history, physical exam and laboratory test 
results. Some of these tests may have been done as part of your regular care. The 
investigator will use this information about you to complete this project.  
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In most cases, the investigator will use your initials and assign a code number to 
your information that is shared with the sponsor. The sponsor and its 
representative may review or copy your personal health information at the project 
site. Regulatory authorities and the Grand Valley State University Human 
Research Review Committee, Pine Rest Christian Mental Health Research 
Committee Institutional Review Board may also review or copy your information 
to make sure that the project is done properly or for other purposes required by 
law.  
 
By signing this Authorization, you allow the investigator to use your personal 
health information to carry out and evaluate this project.  You also allow the 
investigator to share your personal health information with: 
 
   the sponsor and its representatives 
   Grand Valley State University Human Research Review Committee 
   the U.S. Food and Drug Administration (FDA) 
   Other regulatory agencies - e.g. National Institutes of Health (NIH), 
Department     
     of Health and Human Services (DHHS) 
 
Your personal health information may be further shared by the groups above. If 
shared by them, the information will no longer be covered by the Privacy Rule. 
However, these groups are committed to keeping your personal health 
confidential.  
 
You have the right to see and get a copy of your records related to the study for as 
long as the investigator has this information. However, by signing this 
Authorization you agree that you might not be able to review or receive some of 
your records related to the project until after the project has been completed.  
 
You may choose to withdraw this Authorization at any time, but you must notify 
the investigator verbally or in writing.  Notify Alice O. Mwanda of your wish to 
withdraw by contacting Alice O. Mwanda at Cook DeVos Center for Health 
Sciences, Kirkhof College of Nursing, 301 Michigan St. NE, Grand Rapids, 
MI 49503-3314 or  269 532 9288. Or you may contact Dr. Andrea Bostrom  at 
Cook DeVos Center for Health Sciences, Kirkhof College of Nursing, 301 
Michigan St. NE, Grand Rapids, MI 49503-3314 or 616 331 7172.  Or you may 
contact Jeffrey M. Madigan at 300 68th St. SE, Grand Rapids, MI or 616 222 
4570.  If you withdraw from the project and withdraw your Authorization, no new 
information will be collected for study purposes unless the information concerns 
an adverse event (a bad effect) related to the project.  If an adverse event occurs, 
your entire medical records may be reviewed.  All information that has already 
been collected for project purposes, and any new information about an adverse 
event to the project, will be sent to the project sponsor.  
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If you withdraw from the project but do not withdraw your Authorization, new 
personal health information may be collected until this project ends.  This 
authorization expires on 12/31/2014. 
 
If you do not sign this Authorization, you cannot participate in this project or 
receive project-related treatment.  If you withdraw this Authorization in the 
future, you will no longer be able to participate in this project.  Your decision to 
withdraw your Authorization or not to participate will not involve any penalty or 
loss of access to treatment or other benefits to which you are entitled. 
 
DOCUMENTATION OF INFORMED CONSENT  
 
By signing this consent form and HIPAA authorization and by initialing each page, I 
certify I have read this form, I have had the opportunity to ask questions about this 
project and this form, and I have received answers that fully satisfy those questions.  I am 
voluntarily signing this consent form and HIPAA authorization as evidence of my 
decision to participate in this project and I am giving authorization for release of all my 
protected health information relative to project.  
 
I am aware I may withdraw my consent and HIPAA authorization in writing or verbally 
at any time without harming my future medical care or losing any benefits to which I 
might be otherwise entitled. I have been advised that the investigator in charge of this 
project may discontinue my participation in this project if it is felt to be in my best 
interest, if I do not follow the project requirements, or if the project is stopped.  
 
I will receive a signed copy of this Project Informed Consent Form and HIPAA 
Authorization.  
 
 
 
 
By signing this consent form, I have not waived any of my legal rights or released the 
parties involved in this project from liability for negligence.  
 
 
_____________________________________________  
Printed Name of Project Participant  
 
___________________________________________    __________      ___________  
Signature of Project Participant            Date           Time  
 
_____________________________________________  
Printed Name of Person Obtaining Consent  
 
_____________________________________________  __________ ___________  
Signature of Person Obtaining Consent         Date             Time  
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Health-Promoting Lifestyle Profile II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 140 
 
 
 
 
 
 141 
 
 142 
 
 
 143 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix I 
Estimated Caloric Needs 
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Estimated Calorie Needs. Model. Reprinted from “Dietary Guidelines for Americans” United 
States Department of Health and Human Services and United States Department of Agriculture, 
2010. 
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WAECP1318063 
January 5, 2015 
 
Grand Valley State University                            
1 Campus Dr.      
Allendale, MI 49401-9403 
 
Dear Ms. Mwanda; 
 
Thank you for your request for print (Doctoral Dissertation) format of the following from 
Effective Clinical Practice: 
 
Figure 1, Effective Clinical Practice, 1998, Vol1, Chronic Disease Management: What Will It Take 
to Improve Care for Chronic Illness? Wagner EH 
 
Permission is granted to print the preceding material with the understanding that you will give 
appropriate credit to Effective Clinical Practice as the original source of the material. Any 
translated version must carry a disclaimer stating that the American College of Physicians is not 
responsible for the accuracy of the translation. This permission grants non-exclusive, worldwide 
rights for this edition in print (Doctoral Dissertation) format of  for not for profit only. ACP does 
not grant permission to reproduce entire articles or chapters on the Internet unless explicit 
permission is given.  This letter represents the agreement between ACP and ALICE MWANDA, 
MSN FNP for request WAECP1318063 and supersedes all prior terms from the requestor. 
 
Thank you for your interest in Annals of Internal Medicine. If you have any further questions or 
would like to discuss the matter further, please contact me at 856-489-8555 or fax 856-489-4449. 
 
Sincerely, 
 
Gina Brown 
Permissions Coordinator 
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